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DISSERTATION ABSTRACT 
 
Michael Luiz Drummond 
 
Doctor of Philosophy 
 
Department of Biology 
 
June 2015 
 
Title: Spatial Regulation of the Polarity Protein aPKC During Asymmetric Cell Division 
of Drosophila Neuroblasts 
 
The Par complex protein, atypical protein kinase C (aPKC), plays an instrumental 
role in diverse cell polarities.  aPKC is able to restrict substrate localization through a 
phosphorylation-induced cortical exclusion mechanism, allowing for the generation of 
molecularly distinct cortical domains. Thus, controlling the localization of aPKC is central 
to Par-mediated polarity but the mechanism by which aPKC is polarized remains poorly 
understood. In this dissertation I investigated the restriction of aPKC to the apical cortex of 
Drosophila neural stem cells, neuroblasts, as these cells dynamically polarize aPKC 
through repeated asymmetric cell divisions. The polarity created through aPKC 
phosphorylation must be tightly regulated in order to ensure proper balance between self-
renewal and differentiation.  
To begin, I investigated whether or not aPKC’s so called ‘maturation’ by PDK1 
phosphorylation is required for aPKC activity and localization. We found that aPKC’s 
phosphorylation by PDK1 is required for both polarity and full activity. An aPKC 
containing an unphosphorylatable activation loop mutation localizes symmetrically around 
the cortex in a manner independent of its binding partner, Par-6, suggesting that aPKC 
could interact with the cortex by an unknown mechanism.  
To investigate how aPKC is able to localize to the cortex independent of Par-6, I 
 v 
 
used an in vivo structure function analysis of domains within aPKC, accompanied by 
biochemical approaches.  I identified a necessity for the aPKC C1 domain for binding to 
the neuroblast cortex. This interaction is mediated by negatively charged phospholipids. 
Neither aPKC interaction, with phospholipids or Par-6, is sufficient to restrict aPKC to the 
apical cortex. Thus, aPKC polarization utilizes a dual interaction mechanism that takes 
advantage of both protein-lipid and protein-protein interactions, and proper control of each 
of these signals is required to prevent neuroblast division defects. One interaction, mediated 
by the C1, is a general cortical targeting mechanism, whereas the other specifies 
polarization mediated by Par complex interactions. We conclude that a conformational 
change induced by these interactions activates aPKC’s catalytic activity, thereby coupling 
localization and activity.  
This dissertation includes unpublished co-authored material.  
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CHAPTER I 
MOLECULAR CONTROL OF ATYPICAL PROTEIN KINASE C: TIPPING 
THE BALANCE BETWEEN SELF-RENEWAL  
AND DIFFERENTIATION 
 
Chapters I, II, and III contain unpublished co-authored material. 
The manuscript for Chapter I was written by Michael Drummond and Kenneth Prehoda. 
 
INTRODUCTION 
Complex organisms are faced with the challenge of generating and maintaining 
diverse cell types, ranging from simple epithelia, to neurons and motile immune cells 
(Clevers et al., 2014; Kohwi and Doe, 2013; Seita and Weissman, 2010). To meet this 
challenge, a complex set of regulatory pathways controls nearly every aspect of cell 
growth and function, including genetic and epigenetic programming, cytoskeleton 
dynamics, and protein trafficking. Given the far reach of cell fate specification pathways, 
it is not surprising that their malfunction can be catastrophic for both development and 
tissue homeostasis in adult organisms. Furthermore, the promise of stem cells as a 
therapeutic derives from their ability to deftly navigate the multitude of pathways that 
control cell fate (Chen et al., 2013, 2013; Kreso and Dick, 2014; Segers and Lee, 2008). 
Our understanding of the molecular components that make up these pathways has 
increased dramatically, and recent work has uncovered a key role for the atypical Protein 
Kinase C  (aPKC), best known as a member of the Par polarity complex, as a key 
regulator of cell fate decisions in metazoans (Doe, 2008; Homem and Knoblich, 2012; 
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Tepass, 2012). Here we review what is known about how aPKC is controlled, how aPKC 
controls downstream factors to specify cell fate, and the functional interplay between 
polarity and cell fate specification. 
PKC family kinases are ubiquitous components of cellular signaling pathways. 
Although they have long been thought to be oncogenes, the recent discovery that inactive 
PKCs are correlated with cancer indicates that they may instead be tumor suppressors 
(Antal et al., 2015). In animals, PKCs are commonly divided into three subfamilies  
(yeast contain a single PKC), including the conventional, novel, and atypical (Newton, 
2010). This last group contains the iota and zeta isoforms in mammals, and a single 
isoform in flies and worms. All family members contain a catalytic domain at the COOH-
terminus connected to NH2-terminal regulatory domains. Each isoform is specialized by 
their kinase domain’s specificity, which determines the repertoire of substrates that they 
can phosphorylate, and the regulatory elements that determine when and where substrates 
will be phosphorylated( Newton, 2010)  (Figure 1.1A). For example, diacylglycerol  
(DAG) activates the conventional and novel isoforms, leading to phosphorylation of a 
distinct set of substrates, but DAG does not activate atypical PKCs (Colón-González and 
Kazanietz, 2006; Giorgione et al., 2006; Newton, 2010; Pu et al., 2006). The somewhat 
unique role of aPKC in cell fate specification arises from these specializations: the kinase 
domain phosphorylates targets important for cell fate, and the regulatory elements are 
responsive to upstream components that coordinate cell fate changes (Doe, 2008; Homem 
and Knoblich, 2012; Prehoda, 2009). Here we focus on recently discovered aPKC 
substrates that regulate cell fate, and progress in understanding how aPKC activity is 
coordinated with cell fate decisions.   
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Although aPKCs have a different complement of upstream regulators compared to 
their conventional and novel counterparts, they share several important regulatory 
elements  (Figure 1.1A). Perhaps most important is the “pseudosubstrate”, which has 
many of the sequence characteristics of a normal substrate so that it can bind in the kinase 
domain active site, but an alanine at the position that would be phosphorylated prevents 
progression through the catalytic cycle (Graybill et al., 2012; Newton, 2010). 
Determining how the pseudosubstrate is removed from the kinase domain’s active site is 
a key part of understanding PKC activation mechanisms, but other domains, such as the 
C1, may directly repress kinase activity (Graybill et al., 2012; Lopez-Garcia et al., 2011). 
The C1 cysteine rich domain is directly COOH-terminal to the pseudosubstrate in all 
PKCs, and in the single structure of a full-length PKC, the C1 binds a lobe of the kinase 
domain where it can inhibit activity (Leonard et al., 2011). aPKCs is distinguished from 
the other family members by the presence of a PB1 domain that heterodimerizes with 
certain PB1s from other proteins, and a COOH-terminal PDZ ligand sequence (Hirano et 
al., 2004; Lamark et al., 2003; Newton, 2010; Noda et al., 2003). The mechanisms by 
which these domains are used to control aPKC’s activity are just now being uncovered.  
PKCs are also commonly regulated by post-translational modification  (Figure 
1.1A). A series of two or three phosphorylations within their kinase domain is required 
for activity (Borner et al., 1989). These phosphorylations occur at three distinct places: 
the activation loop, the turn motif, and the hydrophobic motif (Newton, 2010)  (Figure 
1.1A). Phosphoinositide-dependent kinase 1 (PDK1) phosphorylates the activation loop, 
whereas the turn motif is autophosphorylated (Chou et al., 1998; Dutil et al., 1998; 
Newton, 2010). aPKC isoforms possess a phosphomimetic residue at the hydrophobic 
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motif, and therefore it does not require phosphorylation of this residue for activation. The 
role of these phosphorylations in regulating aPKC is unclear, as structural evidence 
suggests that they may not be required for activity (Wang et al., 2012). 
As a regulator of cell polarity, perhaps its most-studied function, aPKC is a 
member of the Par  (partitioning defective) complex, which includes Par-3  (Bazooka in 
flies), and Par-6 (Goldstein and Macara, 2007; Suzuki and Ohno, 2006). Polarity is 
essential for many aspects of cell function, and as described below, can also be critical 
for cell fate specification. The Par complex is found in diverse polarized cell types to 
create mutually exclusive cortical domains (Prehoda, 2009; Tepass, 2012)  (Figure 1.1B). 
In the current model for Par complex function, aPKC is a key output of Par complex 
activity as it phosphorylates downstream targets to displace them into the cytoplasm 
(Prehoda, 2009). These substrates can localize to cortical regions that lack the Par 
complex but are removed from the cortex once they enter the Par domain  (Figure 1.1B). 
Thus, two key aspects of polarity are ensuring active aPKC is targeted to the proper 
cortical areas and coupling substrate phosphorylation to cortical displacement. Although 
these are fundamental questions in polarity, our understanding of both is still in its 
infancy. Furthermore, as described below, aPKC’s role in fate specification appears to 
involve aspects of its function that are independent of polarity regulation. 
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Figure 1.1. PKC family kinases, regulation and function of atypical Protein Kinase 
C. (A) Schematic of the protein kinase C family showing domain architectures, 
demonstrating both common and unique aspects of each PKC family member  (PS = 
pseudosubstrate; C1 and C2 are cysteine rich domains; PB1 Phox/Bem1 domain). (B) 
Schematic of Par-mediated polarity mechanism. aPKC generates cellular polarity through 
phosphorylation and exclusion of cortically localized substrates  (pink). (C) Activation of 
aPKC by Par-6 binding. Par-6’s interaction with aPKC’s PB1 domain disrupts the 
pseudosubstrate’s inhibition of the kinase domain. The C1 domain may also play a role in 
regulating aPKC kinase activity. 
 
Fate determinant segregation by aPKC during asymmetric cell division 
 
Asymmetric cell division  (ACD) is a highly dynamic process that generates 
daughter cells with distinct fates, typically with one daughter retaining the mother’s fate 
and the other differentiating (Doe, 2008; Homem and Knoblich, 2012). It is aPKC’s role 
in polarity that underlies the differential fates assumed by each daughter cell. This 
function has been most extensively studied in the Drosophila neuroblast  (NB), a neural 
progenitor cell that is found in both the embryonic and larval nervous systems. Early in 
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mitosis, the NB begins to polarize such that by metaphase aPKC and the rest of the Par 
complex localize to one half of the cell cortex, while neuronal fate specification factors 
localize to the other half. Because the mitotic spindle is aligned with cortical polarity, the 
cytokinetic furrow bisects the two cortical domains: one daughter cell is formed from the 
cortex containing the Par complex, and the other forms from the cortex with 
differentiation factors bound.  
NBs with incorrect levels of aPKC activity fail to asymmetrically divide and can 
exhibit characteristics of tumor cells (Homem and Knoblich, 2012). Excess aPKC 
activity leads to indefinite replication capacity (Caussinus and Gonzalez, 2005), whereas 
NBs with inadequate activity are unable to faithfully segregate cell fate determinates, 
leading to premature quiescence and differentiation (Lee et al., 2006a; Rolls et al., 2003). 
NB self-renewal and neuronal differentiation are both dependent on when and where 
aPKC is active, making the mechanisms that control aPKC localization and activity 
fundamental to asymmetric cell division.   
The Rho GTPase Cdc42 is a key regulator of the Par complex in NBs and other 
polarized cells. GTP-bound Cdc42 interacts with the semi-crib and PDZ domain of Par-6 
causing a conformational change, which is essential for aPKC polarization (Atwood et 
al., 2007; Garrard et al., 2003; Hutterer et al., 2004). Par-6 contains a PB1 domain that 
binds aPKC’s PB1 and this interaction, via an unknown mechanism, displaces the 
pseudosubstrate from the kinase domain active site (Graybill et al., 2012; Noda et al., 
2003)  (Figure 1.1C). Par-6 is required to recruit aPKC to the cortex, where lipid binding 
can play a direct role in the activation of aPKC downstream of phosphatidylionositol 3-
kinase  (PI3K) by binding phosphatidylinositol 3,4,5-phosphate  (PIP3) (Bandyopadhyay 
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et al., 1999; Standaert et al., 1997, 2001). The lipid ceramide also activates aPKC by 
directly interacting with the kinase domain, an interaction that is important for junction 
formation in epithelia and signaling during cellular stress conditions (Bourbon et al., 
2000; Wang et al., 2009). Coupling of aPKC protein-protein and protein-lipid interactions 
to activation provides an elegant mechanism for ensuring that aPKC is active at the right 
place and time. Cdc42 may also play a direct role in controlling aPKC’s kinase activity as 
the Par-6 semi-CRIB and PDZ are important for full activation of aPKC by Par-6, further 
coupling aPKC localization and activity to the NB apical cortex (Atwood et al., 2007; 
Hutterer et al., 2004; Lin et al., 2000). Loss of either Par-3 or Par-6 leads to improper 
aPKC localization, defective asymmetric cell division, and improper development 
(Atwood et al., 2007; Petronczki and Knoblich, 2001; Rolls et al., 2003).   
While Cdc42 and Par-6 are critical for increasing the amount of cortically 
localized, active aPKC, the neoplastic tumor suppressor Lgl is an important repressor of 
localization and activity that helps ensure the basal cortical domain remains free of aPKC  
(and therefore bound to neuronal fate determinants) (Betschinger et al., 2003; Lee et al., 
2006b). The mechanism by which Lgl inhibits aPKC has remained enigmatic. In NBs 
lacking Lgl activity, aPKC activity is no longer restricted to the apical cortex leading to 
an increase in proliferation and a loss of apico-basal polarity(Lee et al., 2006b). aPKC 
counteracts Lgl’s repression by phosphorylating it and displacing it into the cytoplasm 
(Betschinger et al., 2003). How Lgl inhibits aPKC’s localization to the basal cortex 
remains unknown. 
While aPKC interactions with the Par complex and Lgl may form the core 
elements of the asymmetric cell division regulatory machinery, other players have been 
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recently identified. Dynamin associated protein-160  (Dap160) regulates both aPKC 
localization and kinase activity (Chabu and Doe, 2008). It co-localizes with the Par 
complex at the apical cortex of dividing NBs and interacts with both aPKC and Par6. 
Dap160, through an unknown mechanism, also helps ensure that aPKC is properly 
polarized and does not enter the basal cortical domain. Other factors that control aPKC 
activity and localization include Clueless (Goh et al., 2013) and Canoe/afadin (Choi et 
al., 2013; Speicher et al., 2008), although the mechanisms are poorly understood. 
Besides excluding neuronal fate determinants from the self-renewed NB, aPKC 
also plays a direct role in maintaining NB fate. The transcription factor Zif represses NB 
formation and in NBs lacking Zif aPKC is unpolarized (Chang et al., 2010). The aPKC 
gene contains Zif binding sites and Zif appears to repress aPKC expression. Furthermore, 
Zif is an aPKC substrate and phosphorylation prevents its entrance into the nucleus, 
forming a feedback loop that regulates aPKC expression and localization.  
Activating aPKC at the NB apical cortex is critical for restricting neuronal fate 
determinants to the basal cortex. These proteins include the coiled-coiled protein Miranda 
with its cargo protein, the transcription factor, Prospero  (Pros; Prox1 in mammals), and 
the translational regulator Brain Tumor  (Brat; TRIM3 in mammals), as well as the Notch 
signaling regulator Numb (Doe, 2008; Homem and Knoblich, 2012). Following mitosis, 
these determinants induce conversion into a ganglion mother cell  (GMC) by preventing 
self-renewal and promoting differentiation. Pros is a homedomain transcription factor 
that translocates to the GMC nucleus and activates genes that specify differentiation 
while repressing genes that are necessary for self-renewal (Doe, 2008). High Pros 
expression in NBs is sufficient to drive their differentiation (Bayraktar et al., 2010) while 
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intermediate levels induce quiescence (Lai and Doe, 2014). Differentiation is aided by the 
translational repressor Brat, which regulates important proliferation signals including 
Cyclin E, β-Catenin, dMyc, and Mad (Betschinger et al., 2006; Harris et al., 2011; 
Komori et al., 2014), and the repressor of Notch signaling, Numb (Knoblich et al., 1995; 
Lee et al., 2006a).  
The role of aPKC in specifying fate determination during asymmetric cell 
division is primarily related to its function in regulating cell polarity. More recently, 
aPKC signaling has been found to directly control cell fate decisions through 
phosphorylation of cell cycle inhibitors, transcription factors, and growth pathway 
signaling. In this section we review these new findings and discuss how aPKC interfaces 
with important developmental pathways, Hedgehog, Wnt, and Jak/STAT to control stem 
cell fate decisions.  
 
Regulation of the cell cycle by aPKC 
Cell fate specification is usually tightly coupled to the cell division cycle. For 
example, in certain contexts a prolonged G1 cell cycle phase leads to differentiation, 
while a shortened G1 promotes proliferation  (i.e. self-renewal) (Calegari and Huttner, 
2003; Lange and Calegari, 2010). Recent evidence from the Xenopus neuroectoderm 
suggests that G1 is controlled in part by the inhibition of G1 specific cyclin/cdks (Lange 
et al., 2009). Although many aPKC functions involve its cytoplasmic activity, aPKC is 
found in the nucleus of progenitor cells in this tissue (Sabherwal et al., 2009) consistent 
with a role in transcriptional regulation. This seems to be the case for at least one cell-
cycle regulating protein in Xenopus progenitor cells, p27xic. p27xic is a CIP/KIP protein 
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family of cyclin-dependent kinase inhibitors  (CDKIs) that prevents the G1 to S transition 
by inhibiting cyclin-dependent kinase 2  (Cdk2) through binding and sequestering it from 
the nucleus  (Figure 1.2A). In this manner, the level of p27xic expression in the 
progenitor cells can indirectly affect the decision to proliferate or differentiate by 
controlling G1 length. But what controls the level of p27xic? Recent work has 
demonstrated that p27xic is an aPKC substrate and phosphorylation regulates its ability to 
inhibit the G1 to S transition. Phosphorylation prevents p27xic’s binding to Cdk2 
providing a simple, but elegant method for coupling aPKC activity to cell cycle control, 
and ultimately the decision to proliferate or differentiate (Sabherwal et al., 2014)  (Figure 
1.2B).  
 
 
Figure 1.2. aPKC regulation of the cell cycle. (A) When aPKC levels are low, p27Xic1 
is able to elongate the G1 to S transition by binding to Cdk2, which can lead to 
differentiation in Xenopus neuroectoderm progenitor cells. (B) When aPKC levels are 
high, p27Xic1 phosphorylation by aPKC blocks p27Xic1 binding of Cdk2, shortening the 
G1 to S transition to promote proliferation. 
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Transcriptional programming by aPKC 
Hedgehog  (HH) signaling is important for cell fate decisions that specify the 
animal body plan (Briscoe and Thérond, 2013). In the absence of HH ligand, Patched  
(Ptch) represses HH signaling through inhibition of the receptor Smoothened  (Smo) 
(Varjosalo and Taipale, 2008)  (Figure 1.3). When HH binds Ptch at the membrane, 
transcriptional activators such as GLI  (Cubitus interruptus in Drosophila) become active 
(Varjosalo and Taipale, 2008). This pathway can regulate stem cell proliferation versus 
differentiation decisions (Brownell et al., 2011; Ruiz i Altaba et al., 2002) and is often 
reactivated during the initiation and progression of cancers such as basal cell carcinomas  
(BCCs) and lung squamous cell carcinomas  (LSCCs) (Ng and Curran, 2011; Rubin et 
al., 2005). Binding to Ptch requires numerous HH post-translational modifications 
including specific proteolysis followed by palmitoylation by HH acyl transferase  
(HHAT) (Varjosalo and Taipale, 2008). Once HH ligand binds to Ptch, Ptch no longer 
inhibits Smo, resulting in translocation of GLI to the nucleus and subsequent activation of 
proliferative genes(Briscoe and Thérond, 2013). Recently, aPKC has been found to 
regulate multiple points within the HH pathway. Activity of aPKC leads to upregulation 
of the HH ligand, phosphorylation of the receptor Smoothened, and activation of the 
bifunctional transcriptional regulator of HH signaling, GLI (Atwood et al., 2013; Jiang et 
al., 2014; Justilien et al., 2014)  (Figure 1.3). 
There are several mechanisms by which aPKC regulates HH signaling. First, 
expression of the HHAT enzyme is dependent on aPKC activity. This control occurs by 
aPKC’s phosphorylation of SOX2, an important transcriptional regulator of stem cell 
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maintenance. SOX2 modification by aPKC allows it to bind the HHAT promoter region 
(Justilien et al., 2014)  (Figure 1.3). This leads to an increase in functional HH ligands. 
Upregulation of HHAT by aPKC can be important for tumorigenic growth by 
maintaining stemness, as has been demonstrated for LSCC oncospheres (Justilien et al., 
2014).  
HH signaling can also be regulated by aPKC downstream of the Ptch receptor. 
The GLI1 transcription factor is an aPKC substrate (Atwood et al., 2013), and, as with 
SOX2, phosphorylation activates transcription of GLI1 target genes including aPKC 
itself  (Figure 1.3). This positive feedback loop can lead to the development and 
progression of basal cell carcinomas  (BCCs) independent of Smo activation of GLI1 
(Atwood et al., 2013)  (Figure 1.3). Currently, Smo inhibitors are used to treat BCCs but 
the tumors can develop resistance (Atwood et al., 2015; Briscoe and Thérond, 2013). 
Inhibition of aPKC signaling inhibits BCC tumor-growth indicating that inhibitors could 
have therapeutic potential for treating BCCs ( Atwood et al., 2015). In Drosophila, aPKC 
phosphorylates Smo and GLI  (Cubitus interruptus in Drosophila) to polarize them 
basolaterally, thereby promoting HH signaling during early wing development (Jiang et 
al., 2014). However, the molecular mechanism by which aPKC activity is controlled 
during HH signaling remains unclear.  
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Figure 1.3. aPKC regulation of Hedgehog signaling. In basal cell carcinomas (BCCs) 
and lung squamous cell carcinomas (LSCCs) aPKC is able to phosphorylate GLI (BCCs) 
and SOX2 (LSCCs) transcription factors. These phosphorylations can lead to positive 
feedback, upregulating HH signaling genes including HHAT and aPKC itself. This 
activation can occur independently of HH ligand receptor binding. In the Drosophlia 
developing wing, aPKC phosphorylates the Smoothened receptor to regulate its activity 
and its subsequent proper development. 
 
aPKC regulation of Wnt signaling 
Many tissues, such as the epidermal and intestinal epithelia, undergo rapid 
turnover requiring constant differentiation from precursor cells for tissue maintenance. In 
mammalian epidermal models, aPKC regulates cell fate by ensuring proper division 
orientation (Niessen et al., 2013). Adult intestinal stem cells are continually replenishing 
the cells of the epithelium, which is turned over ever 3-5 days (Barker, 2014; Jiang and 
Edgar, 2011). In these adult stem cell models, precise regulation of β-Catenin  (Wnt 
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signaling) and Yap  (Hippo pathway) is required for maintenance of tissue homeostasis 
and prevention of tumor initiation and progression (Azzolin et al., 2014; Clevers et al., 
2014).  
In the absence of Wnt ligands, β-Catenin is degraded by the “destruction” 
complex composed of the tumor suppressor adenomatous polyposis coli  (APC), 
scaffolding protein Axin, glycogen synthase-3  (GSK-3β) and casein kinase 1  (CK1). 
While the complex is intact, β-Catenin is phosphorylated by GSK-3β and degraded by the 
proteasome (Stamos and Weis, 2013). In the absence of nuclear β-Catenin, downstream 
Wnt-dependent target genes are not transcribed, inhibiting proliferative and growth 
signals  (Figure 1.4A). When Wnt is bound to the receptor Frizzled  (FZD) and a co-
receptor, Axin is thought to be degraded and the destruction complex dissociates, 
concomitantly stabilizing β-Catenin levels, allowing for nuclear translocation and binding 
to co-activator TCF/LEF proteins. Ultimately, this leads to the transcription of Wnt-
dependent target genes (Stamos and Weis, 2013)  (Figure 1.4B). Wnt signaling has been 
implicated in polarity through interactions with the Par complex in migratory cells 
(Etienne-Manneville and Hall, 2003). Recent work has shed light on how aPKC might be 
playing a direct roll in Wnt signaling.  
aPKC has now been identified as a component of destruction complex that 
interacts with Yap and β-Catenin (Llado et al., 2015). While best known for their role in 
Hippo pathway signaling (Yu and Guan, 2013), Yap and Yaz also interact with the 
destruction complex (Azzolin et al., 2012, 2014). aPKC phosphorylates both β-Catenin 
and Yap, preventing their nuclear accumulation, thereby inhibiting Wnt and Hippo 
downstream targets required for proliferation and cell growth (Llado et al., 2015)  (Figure 
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1.4). β-Catenin must be phosphorylated at its aPKC phosphorylation site  (either by 
aPKC or another kinase) before GSK-3β can act on it (Amit et al., 2002; Liu et al., 2002). 
Yap activity is increased by aPKC, in a manner that is at least partially independent from 
canonical Hippo signaling. In Drosophila, GSK3b regulates polarity by phosphorylating 
aPKC, which targets it for proteasomal degradation (Colosimo et al., 2010) suggesting 
crosstalk between these pathways.  
 
 
Figure 1.4. aPKC regulation of Wnt signaling. (A) aPKC is part of the destruction 
complex, where it can phosphorylate (1) β-Catenin to prime it for  (2) GSK-3β 
phosphorylation and subsequent proteasomal degradation. aPKC is also able to 
phosphorylate YAP, leading to proteasomal degradation. (B) Loss of aPKC or Wnt 
binding leads to disassembly of the destruction complex and activation of Wnt signaling 
favoring a proliferative state. The fate of aPKC once the destruction complex is 
inactivated is unknown. 
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aPKC regulation of JAK/Stat 
Janus Kinase  (JAK) and Signal transducer and activator of transcription  (Stat) 
are important growth regulators that play a prominent role in development and tumor 
progression (Kortylewski et al., 2005; Yu et al., 2009; Al Zaid Siddiquee and Turkson, 
2008). Numerous signaling pathways activate JAK/Stat by inducing JAK recruitment to 
Stat and subsequent Stat phosphorylation. During IL6 cytokine activation, 
phosphorylation of the Stat3 isoform by JAK leads to Stat3 nuclear translocation where it 
activates proliferation and survival genes and represses differentiation genes (Yu et al., 
2014). Stat3 has also been implicated in the maintenance of cancer stem cells  (CSCs) 
(Magee et al., 2012; Visvader and Lindeman, 2008).  
In a recent study, aPKC activity was found to activate Stat3 in a mammalian 
model of breast cancer (Guyer and Macara, 2015). Activation occurs via aPKC’s 
interaction with the NF-kb signaling pathway, which is up regulated in many human 
cancers (Bassères and Baldwin, 2006). In this system, aPKC becomes active in the 
cytoplasm after loss of polarity where it activates IKKβ, ultimately causing increased IL6 
production (Duran et al., 2003; Win and Acevedo-Duncan, 2008). This leads to a positive 
feedback loop associated with proliferation and tumor progression  (Figure 1.5). Up-
regulation of IL6 by active aPKC in unpolarized cells also occurs in Drosophila models 
that combine polarity loss with oncogenic transformations (Bunker et al., 2015). In fact, 
constitutively active aPKC is sufficient to induce IL6  (Upd in Drosophila) expression, 
although the effect is dependent on the Drosophila ortholog of YAP  (Yki) (Bunker et al., 
2015). Whether or not aPKC induces IL6 through YAP via the canonical Hippo pathway 
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signaling or as part of the destruction complex  (i.e. Wnt signaling), remains to be 
resolved.  
 
 
Figure 1.5. aPKC regulation of JAK/Stat signaling. Loss of polarity leads to 
cytoplasmic aPKC which causes activation of IKKβ, degradation of IκBα, and 
translocation of p65 to the nucleus to upregulate IL6 production. The increase in IL6 
leads to a positive feedback loop with JAK/Stat3 signaling, which, when unregulated, 
leads to proliferation and tumor progression in a breast cancer model. 
 
Concluding remarks 
How cellular diversity is generated during development is one of the most 
fundamental questions in Biology. Once development is complete, homeostasis requires 
the constant activity of progenitor cells to replenish rapidly turned over differentiated 
products. Each of these processes is highly intertwined with proliferation pathways, such 
that defects are commonly associated with tumorigenesis. Our understanding of the 
molecular mechanisms that control cell fate decisions is still in its infancy, but it is now 
clear that the atypical members of the PKC kinase family are involved in many aspects of 
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fate specification. Some of these functions relate to aPKC’s activity in regulating cell 
polarity, but there are newly identified polarity-independent aPKC functions  (both in 
normal and pathological Biology) that are essential for conferring proper cell identity. 
We expect that many more aPKC substrates and regulatory proteins remain to be found, 
and that fitting them into the puzzle of cell fate will help provide a more complete picture 
of this fundamental process. 
QUESTIONS STILL REMAINING IN CELL POLARITY AND REGULATION 
OF APKC: 
 -How is aPKC activated during ACD of Drosophila neuroblasts? 
 -How does aPKC become polarized? 
 -What are the roles of each of the aPKC domains in this process? 
-Are aPKC localization and activation coupled during ACD of Drosophila 
neuroblast? 
 While many of the proteins required for cell polarization have been identified, the 
mechanism by which polarization occurs is still being elucidated. Much of what is 
currently known comes from the use of Drosophila as a model organism. In order to 
attempt to answer the above-mentioned outstanding questions, I used a combination of 
genetic and biochemical approaches to define the mechanisms that are involved in the 
activation and localization of aPKC. 
 
BRIDGE TO CHAPTER II 
In the previous chapter I introduced the importance of the protein aPKC in the 
generation of cellular polarity, as well as its importance in regulation of the cell cycle and 
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transcription factors, all of which govern cell fate decisions. Also, I introduced the 
Drosophila neuroblast as an important model system to investigate the proteins necessary 
to generate polarity and subsequently, the current understanding of the mechanisms by 
which polarity is established. In the next chapter, I seek to answer an outstanding 
question when it comes to the activation of aPKC by the upstream kinase PDK1. 
Biochemical approaches have revealed that PDK1 phosphorylates the activation loop of 
aPKC, which is then autophosphorylated at the aPKC turn motif. It is generally, but not 
universally, accepted that this phosphorylation event is required for aPKC activity. 
Recent crystal structures have even demonstrated that a mammalian aPKC kinase domain 
adopts an active conformation without activation loop phosphorylation. Even less clear, 
is if the observed activity differences between aPKC phosphorylated and 
unphosphorylated at the activation loop, is physiologically relevant. In the next chapter, I 
carefully investigated the importance of activation loop phosphorylation with a highly 
quantitative, in vitro approach. I then explain my work using the Drosophila neuroblast 
as model, demonstrating that phosphorylation of aPKC activation loop and turn motif are 
required for both, catalytic activity, and spatial regulation during asymmetric cell 
division.  
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CHAPTER II 
REGULATION OF NEUROBLAST POLARITY AND SELF-RENEWAL BY 
PHOSPHOINOSITIDE DEPENDENT KINASE 1 
 
This chapter contains unpublished co-authored material 
 
Author contributions: Michael Drummond, Chiharu Graybill, and Kenneth Prehoda 
designed the research; Michael Drummond and Chiharu Graybill performed the research; 
Michael Drummond, Chiharu Graybill, and Kenneth Prehoda analyzed the data; and 
Michael Drummond, Chiharu Graybill, and Kenneth Prehoda wrote the manuscript. 
 
INTRODUCTION 
The generation and maintenance of molecularly distinct cortical domains is 
necessary for a wide range of cellular functions. In many animal cells, cortical polarity is 
regulated by the Par complex, which consists of the proteins Par-3, Par-6, and atypical 
Protein Kinase C (aPKC) (Goldstein and Macara, 2007; Prehoda, 2009). In cells such as 
epithelia, or neural stem cells, the Par complex is confined to a specific cortical domain 
where it excludes cell-type specific proteins such as the tumor suppressor Lethal giant 
larvae (Lgl) and the neuronal fate determinant Miranda (Doe, 2008; Tepass, 2012). 
Cortical exclusion is established and maintained by aPKC, as Par polarized factors are 
substrates that are phosphorylated upon entering the Par cortical domain. Substrate 
phosphorylation inhibits cortical association, ensuring that Par polarized proteins don’t 
  
 
21 
accumulate in the Par domain. Because of the central role of aPKC in Par-mediated 
polarity, slight perturbations in aPKC activity can have severe consequences, such as 
uncontrolled proliferation and metastatic tumor formation (Bunker et al., 2015; Lee et al., 
2006a, 2006b; Parker et al., 2014). Although aPKC activity must by tightly regulated 
both spatially and temporally during cell polarization, the mechanisms that control aPKC 
are poorly understood. Here we have examined the regulation of aPKC from the 
perspective of its membership in the larger family of PKC enzymes. 
The PKC family of protein kinases includes conventional and novel, in addition to 
atypical subfamilies (1 isozymes in flies, 2 in humans). Individual PKC family members 
regulate diverse cellular processes, from proliferation to apoptosis (Antal and Newton, 
2014; Breitkreutz et al., 2007; Newton, 2010). A key difference between atypical PKCs is 
that they are not activated by diacylglycerol (DAG), unlike their conventional and novel 
counterparts (Colón-González and Kazanietz, 2006; Kazanietz et al., 1994). This 
difference arises from a unique regulatory motif architecture as aPKCs lack the DAG-
binding C2 domain (Newton, 2010). Besides these architectural differences, however, all 
family members share a number of key regulatory features. For example, each contains a 
“pseudosubstrate” motif that competes with substrates for active site binding. Par-6 
binding to aPKC has been shown to displace its pseudosubstrate from the kinase domain, 
allowing it to phosphorylate substrates such as Lgl (Graybill et al., 2012). Additionally, 
PKC catalytic domains have several sites that are phosphorylated and these post-
translational modifications can be critical for catalytic activity, although much less is 
known about their involvement in spatial regulation (Newton, 2010).  
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In order to identify genes responsible for regulating aPKC activity and 
localization during polarization, we performed a candidate based RNAi screen to uncover 
genes that perturb self-renewal of Drosophilia neural stem cells (neuroblasts). During 
development, neuroblasts undergo repeated asymmetric cell divisions to generate the 
central nervous system. Early in mitosis, neuroblasts polarize the Par complex to the 
apical cortex where it confines neuronal fate determinants to the basal cortex. Mitotic 
polarity leads to one daughter cell that retains the neuroblast fate (i.e. self renews), and 
another that differentiates.  Thus, proper regulation of aPKC is critical for maintenance of 
the neuroblast pool through self-renewal at each division and this phenomenon can be 
exploited to identify factors that control aPKC activity. 
 
MATERIALS AND METHODS 
Purification of aPKC variants 
HEK293 F cells  (1 x 106 cells/mL) were transfected with aPKC  (pCMV His6-
aPKC 1-606, pCMV His6-aPKC 1-606 K293W, pCMV His6-aPKC 259-606, pCMV 
His6-aPKC 259-606 T422A, or pCMV His6-aPKC 259-606 T574A) and pCMV dPDK-1  
(without any tag) using the 293fectin transfection reagent  (Life Technology). The cells 
were incubated at 37°C for 48-72 hours. To harvest, the cells were resuspended with Ni2+ 
lysis buffer  (50 mM Tris-HCl, pH 7.5, 300 mM NaCl, 1 mM MgCl, 10 mM β-ME, 10 
mM Imidazole, adjusted to pH 7.5 with NaOH). The cells were lysed by passage through 
a 21-gauge needle and the lysate was clarified by centrifugation at 15,000 rpm for 30 
minutes at 4°C. The supernatant was incubated with Ni2+ NTA resins for 45 minutes at 
4°C followed by washing with lysis buffer. Following elution using Ni2+ elution buffer  
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(lysis buffer with 250 mM Imidazole), the eluted proteins were dialyzed at 4°C for 4 
hours against 20 mM Tris-HCl, 50 mM NaCl, 1 mM DTT. The concentration of aPKC 
was determined by comparing its reactivity with an anti-aPKC antibody  (Santa Cruz 
Biotech) with that of a standard of known concentration  (bacterially expressed aPKC 
kinase domain purified and quantified using a Bradford dye binding assay) on a western 
blot.  
 
In vitro kinase activity assay 
aPKC kinase activity was measured as previously described (Graybill et al., 
2012). Briefly, the purified aPKC kinase domain was diluted to concentrations at which 
the incorporation of radiolabeled phosphate from [γ-32P]ATP into MBP-Lgl peptides were 
linear with respect to time and the enzyme concentrations. The diluted enzymes were 
preincubated in the assay buffer  (50 mM Tris-HCl pH 7.5, 100 mM NaCl, 10 mM 
MgCl2) with a wide range of MBP-Lgl peptide concentrations at 30°C for 5 minutes. The 
reactions were initiated by adding 1mM ATP spiked with [γ-32P]ATP  (~1.0 x 106/nmol 
ATP). The reactions were incubated at 30°C for 10 minutes. The reaction mixtures were 
blotted on Grade P81 phosphopaper  (Whatman). The reactions were quenched by 
immediately submerging the blotted P81 paper in 75 mM H3PO4. 5 mL of scintillation 
fluid were added to measure the radioactive decays by liquid scintillation counter. The 
kinetic parameters were calculated by fitting the data to the Michealis-Menten equation in 
GraphPad Prism. 
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Antibodies and immunofluoresence  
Immunoflourescence was performed as previously described (Atwood and 
Prehoda, 2009). In brief, third instar larval brains were dissected and fixed in PBS with 
4% paraformaldhyde for 20 minutes. After being fixed, brains were washed with PBS 
containing 0.1% TX-100 (PBS-T) 3 times (quick rinse) followed by a single 20 minute 
wash. Next, the brains were blocked in PBS with 1% BSA and 0.1 TX-100  (PBS-BT) for 
30 minutes and then incubated with primary antibodies dilluted in PBS-BT overnight at 
4°C on a nutator. Primary antibodies were removed and brains were washed 3 times with 
PBS-BT for 15 minutes each. Following washes, brains were incubated in secondary 
antibodies diluted in PBS-BT for 2 hours at room-temperature in the absence of light. 
Finally, brains were wash 3 times with PBS-T for 15 minutes each and placed in 
Vectashield H-1000 prior to mounting on slides.  
Primary antibodies for this study included: rabbit anti-aPKCζ (1:1000; C-20, 
Santa Cruz Biotechnology), rabbit anti-p-aPKCζ (Thr 410) (1:1000; sc-12894-R, Santa 
Cruz Biotechnology), rabbit anti-p-aPKCζ (T560) ( 1:1000; EP2037AY, Abcam), guinea 
pig anti-Baz (1:1000; Doe lab), Chicken anti-GFP (1:5000; ab13970, Abcam) mouse 
anti-HA  (1:500; Covance), guinea pig anti-Miranda and Rat anti-Miranda (1:500; Doe 
lab), and rat anti-Par6 (1:1000; in house). Secondary antibodies were donkey anti-guinea 
pig 405 and donkey anti-rat 405 (1:500; Jackson Immuno-Research Laboratories) donkey 
anti-mouse 488 and donkey anti-chicken 488 (1:500; Jackson Immuno-Research 
Laboratories), goat anti-rat 555 (1:500; Invitrogen), donkey anti-rabit 649 and donkey 
anti-rat 649 (1:250; Jackson Immuno-Research Laboratories). 
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Confocal images were collected using a Zeiss 700 equipped with a 40x oil 
immersion objective/1.43 NA or an Olympus Fluorview 1000 equipped with a 40x oil 
immersion objective/1.30 NA. Figures were generated using Fiji, Adobe Photoshop, and 
Adobe Illustrator. Quantifications were performed using Graphpad Prism. 
 
Fly strains and genetics 
We used w1118 as our wild-type strain. In order to generate aPKC FL, aPKC 
K293W, aPKC T422A, and aPKC T574A expressing flies, the coding sequence of each 
was subcloned into a PUAST-attb plasmid containing a 5’ Hemagglutinin  (HA) and 
transformants were created and isolated by Genetic Services using standard techniques. 
Attp2, on chromosome 3R was the chosen landing site for our transgenics. For 
overexpressions, we used Inscuteable-GAL4 at 30°C and dissected larvae when they 
became wandering third instar larvae (approximately 76 ALH at 30°C). RNAi was 
performed using Worniu-GAL4, UAS-DCR2  (Doe Lab) crossed to either PDK1 RNAi 
line (Bloomington stock number 27725 and VDRC 109812) at 30°C and dissected when 
their wild type counterparts were wandering third instar larvae.  
MARCM clones were generated as previously described (Lee and Luo, 1999). In 
brief, FRTG13aPKCk06403/Cyo virgins were crossed to ;;UAS-aPKC FL, ;;UAS-HA:aPKC 
T422A, ;;UAS-HA:aPKC T574A, or ;;UAS-HA:aPKC K293W  male flies between 3 and 9 
days old. F1s males lacking Cyo were collected and crossed to virgin elav-GAL4, UAS-
mCD8:GFP, hs:flp ; FRTG13, tubPGal80  (Doe Lab). Larvae were heat shocked 24 hours 
after larval hatching at 37°C for 90 minutes and again 10-16 hours after the first heat 
shock. Larvae were allowed to grow to the wandering third instar larval stage at 22°C or 
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25°C and then dissected and immunostained. aPKC null clones were positively marked 
with GFP and  overexpressed  aPKC variants were detected using mouse anti-HA.  
 
RESULTS 
Identification of PDK1 as a regulator of neuroblast self-renewal 
To identify factors that regulate aPKC activity during Drosophila neuroblast 
asymmetric cell division, we screened a panel of UAS-driven RNAi’s directed against 
putative PKC family regulators for their effect on neuroblast self renewal. In the larval 
central nervous system, each brain lobe normally contains approximately 100 central 
brain neuroblasts, as assessed by the markers Deadpan (Dpn) and Mira (Figure 2.1A), but 
defects in self-renewal can dramatically reduce the neuroblast population (Doe, 2008; 
Homem and Knoblich, 2012). We found that expression of an RNAi directed against 
phosphoinositide dependent kinase 1 (pdk1) resulted in a significant decrease in the 
number of larval central brain neuroblasts, and we observed a similar effect with an RNA 
targeted to a different region of the pdk1 gene (Figure 2.1B-D). Apoptosis can also lead 
to a reduction in neuroblast number, but we found that expression of the apoptotic 
inhibitor p35 did not rescue the effects of pdk1 RNAi (Figure 2.1D) 
PDK1 acts upstream of PKC family members by phosphorylating their activation 
loop segment (residue T422 in Drosophila aPKC), a modification that can be a 
prerequisite for activity (Chou et al., 1998; Dutil et al., 1998; Le Good et al., 1998; 
Standaert et al., 1997, 2001). However, there is conflicting evidence for the role of 
activation loop phosphorylation in aPKC activity (Ranganathan et al., 2007; Wang et al., 
2012). The kinase domain’s turn motif (T574) can also be phosphorylated, which has 
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been though to be an autocatalytic event, although recent evidence suggest that this may 
not be case (Cameron et al., 2009; Le Good et al., 1998) . We stained neuroblasts 
expressing pdk1 RNAi with an antibody specific to T422 phosphorylated aPKC (anti 
pT410) and found that the apical cortical signal was significantly reduced compared to 
wild-type cells. Surprisingly, we also observed a large reduction in Par-6 apical staining 
in the pdk1 RNAi neuroblasts, indicating that PDK1 is required for Par complex targeting 
to the apical cortex (Figure 2.1F-H). Miranda’s polarization was largely unaffected by 
PDK1 knockdown indicating that sufficient polarized aPKC activity remained to prevent 
Miranda from entering the Par cortical domain (Figure 2.1F-H). Although we were 
unable to visualize endogenous PDK1, an ectopically expressed, tagged version of the 
protein localized throughout the neuroblast cytoplasm, with possible cortical enrichment 
(Figure 2.1I). 
 
Active loop and turn motif phosphorylation are required for full Drosophila aPKC  
 
kinase activity in vitro 
 
The effect of PDK1 knockdown could result from the reduction in phosphorylated 
aPKC activation segment, or from the loss of some other PDK1 activity (e.g. 
phosphorylation of another PKC family member or other substrate). To determine which 
aspects of the pdk1 phenotype arise from direct phosphorylation of aPKC, we generated 
non-phosphorylatable aPKC variants – one for the activation segment (T422A) and one 
for the turn motif (T574A) – and measured their activity both in vitro and in vivo (Figure 
2.2A).  The importance of kinase domain phosphorylations for aPKC’s catalytic activity 
has been unclear because of conflicting in vitro and structural data, which demonstrated 
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that substrate binding to a kinase domain that lacked the modifications. To help resolve 
this controversy, we used a quantitative approach measuring activity over a wide range of 
substrate (a peptide from Lethal giant larvae) concentrations. This allowed us to avoid 
artifacts associated with single substrate concentration assays and to detect differences in 
both Michaelis-Menten kinetic parameters, KM and kcat. We purified Drosophila aPKC 
kinase domains (residues 259-606; the full length protein is autoinhibited) containing the 
T422A or T574A mutations and one with a “kinase-dead” K293W mutation, which 
prevents ATP-binding, in addition to the wild-type protein. When compared to the 
activity of wild-type aPKC, both the T422A and T574A variants had reduced catalytic 
activity (Figure 2.2B). Both mutations caused KM to increase, consistent with a role for 
the phosphorylations in substrate binding, but kcat was most affected indicating that they 
serve a critical function in the catalytic step (Figure 2.2C). Thus, we find that 
modification of aPKC’s kinase domain is required for full catalytic activity, but that 
significant residual activity remains even in the absence of these phosphorylations.  
 
Kinase domain phosphorylations are required for aPKC activity and polarization in  
 
neuroblasts 
 
Although the unphosphorylated aPKC variants have residual catalytic activity, we 
sought to determine if this level of activity is sufficient to mediate function in vivo. We 
generated transgenic Drosophila lines containing HA-tagged WT, T422A, or T574A 
aPKCs under the control of the UAS promoter and drove their expression using 
Inscutable-Gal4, which is specific for the neuroblasts of the larval brain. Expression of 
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Figure 2.1. Loss of PDK1 impairs neuroblast self-renewal and proper aPKC 
activation loop phosphorylation. (A-C) Representative z-slice of either wild type or 
PDK1 RNAi expressing brain lobes showing the central brain (CB) and the optic lobe 
(OL) stained with aPKC/PH3, Miranda, and Deadpan. RNAi was driven using worniu-
GAL4, UAS-DCR2 at 30°C until wild type counterparts reached the wandering third 
instar larval stage. Scale bars represents 20 µM (A) Wild type average central brain 
neuroblasts per lobe 103.83 ± 2.04 sd. (B) PDK1 RNAi (27725) average central brain 
neuroblasts per lobe 32.16 ± 1.47 sd. (C) PDK1 RNAi (109812) average central brain 
neuroblast per lobe 30 ± 15.19 sd. (D) Quantification of total central brain neuroblast for 
six lobes per condition with the orange column representing PDK1 RNAi (109812) with 
expression of P35 to block apoptosis, average 25.67 +/1 5.24 sd. *** Represents a P-
value < 0.0001. Mean and SEM are plotted. (E) Ribbon diagram representing the crystal 
structure of PKCι kinase domain bound to a Par-3 peptide (PDB 4DC2). The peptide 
binding, activation loop, and turn motif are shown. (F-H) Wild type or PDK1 RNAi 
expressing neuroblasts labeled with Par-6, p-410 aPKC (activation loop specific 
antibody), and Miranda. (F) Wild type showing proper apico-basal polarity. (G) PDK1 
RNAi (27725) showing reduced Par-6 and activation loop labeling, but maintained 
Miranda polarization. (H) PDK1 RNAi (109812) showing reduced Par-6 and activation 
loop labeling, but maintained Miranda polarization. (J) Overexpression of a FLAG-
tagged PDK1 demonstrating the cytoplasmic with possible cortical localization of PDK1.  
  
 
30 
 
 
Figure 2.2. The effects of mutation of the activation loop or the turn motif on aPKC 
catalytic activity. (A) Domain architecture of aPKC with amino acid sequence 
alignments of activation loop and turn motif regions containing the phospho-accepting 
Thr residues (highlighted in red). The numbering is based on Drosophila aPKC. (PB1 
Phox/Bem1 domain; PS = pseudosubstrate; C1 is a cysteine rich domains). (B) Kinetic 
analyses of aPKC activity, showing that the mutation from Thr to Ala in either the 
activation loop or the turn motif resulted in increased KM and reduced kcat. (C) The 
summary values of KM and kcat of aPKC variants used in kinetic analyses.  
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WT aPKC had no detectable effect on neuroblast polarity or aPKC localization (Figure 
2.3B). Slight perturbations in aPKC activity can alter larval brain neuroblast number, 
however we found that the neuroblast count from Insc-Gal4>WT aPKC FL (data not 
shown) animals were normal. The ability of neuroblasts to accommodate increased aPKC 
expression suggests that the regulatory pathways that control its activity are robust 
enough to maintain aPKC activity within an appropriate functional range.  We also 
assessed Insc-Gal4>aPKC function by rescuing aPKCk06403 positively marked mutant 
clones. In aPKCk06403 clones, the lack of apical aPKC activity causes Miranda to become 
depolarized. As seen in Figure 2.3, transgene expressed aPKC localized apically in 
mutant clones and restored Miranda polarity by confining it to the basal cortex indicating 
that transgene expressed aPKC is functional in this context. 
We first examined the role of the T422 phosphorylation in neuroblast polarity. 
Neuroblasts expressing both endogenous and the non-phosphorylatable T422A aPKC 
variant had unperturbed Miranda localization (Figure 2.3C), indicating that basal polarity 
was unaffected. Surprisingly, however, aPKC T422A was no longer restricted to the 
apical cortex, localizing around the entire cortex including colocalizing at the basal 
domain with Miranda (Figure 2.3C). The colocalization with Miranda indicates that the 
protein is inactive, either because the residual catalytic activity of aPKC T422A observed 
in vitro is insufficient to displace Miranda from the cortex, or the protein is autoinhibited. 
Next, we examined the phosphorylation state of the activation loop and turn motif in 
these cells. Neuroblasts expressing aPKC T422A had limited cortical pT422 signal 
(Figure 2.3C). While this is consistent with the inability of T422A aPKC to be 
phosphorylated at this site, the reduced apical staining with this antibody indicates that 
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the endogenous protein is also affected. The phosphorylated turn motif antibody (pT574) 
yielded a depolarized cortical signal similar to the HA staining for the transgenic protein 
(Figure 2.3C’). We interpret these results in the following manner:  the reduction in 
pT422 signal at the apical cortex is a consequence of aPKC T422A competition with 
endogenous aPKC, although sufficient endogenous aPKC remains to exclude Miranda 
and phosphorylate T574 on both the wild type and T422A proteins. We also examined 
aPKC T422A in aPKCk06403 clones to determine if it could rescue polarity loss, and to 
ensure that the presence of wild-type aPKC does not influence the transgenically 
expressed protein’s behavior. We found that aPKC T422A was unable to rescue the loss 
of Miranda polarity in aPKCk06403 clones (Figure 2.3I). Furthermore, aPKC T422A 
localized throughout the neuroblast cortex, as we observed in the overexpression context. 
These results indicate that T422 phosphorylation is required for aPKC activity, either 
because of its role in catalytic activity or a possible role in activation of the autoinhibited 
conformation. Additionally, phosphorylation at this site is necessary for aPKC polarity by 
preventing its localization at the basal cortex. 
Next, we examined the role of turn motif T574 phosphorylation in neuroblast 
polarity. Phosphorylation at this site was thought to occur autocatalytically in trans 
following activation segment phosphorylation by PDK1, although recent evidence 
suggests that other kinases (e.g. mTOR) may directly modify the turn motif (Ikenoue et 
al., 2008; Li and Gao, 2014). Similar to the unphosporylatable activation segment aPKC 
variant, aPKC T574A expressed alongside endogenous aPKC localized around the entire 
  
 
33 
  
Figure 2.3. Activation loop phosphorylation is required for spatial restriction and 
activity of aPKC. (A-C and A’-C’) Inscuteable-GAL4 was used at 30°C and wandering 
third instar larvae were dissected. Anti-HA stains for the overexpressed proteins, p-410 
labels the activation loop, p-560 labels the turn motif, and Miranda. (A-A’) Wild type 
neuroblast during mitosis showing apical staining for both activation loop and turn motif 
specific antibodies, with basally restricted Miranda. (B-B’) aPKC FL localizes apically 
showing proper activation loop and turn motif labeling, with basally restricted Miranda 
(C-C’) aPKC T422A localizes around the entire cortex with reduced activation loop 
labeling, but maintenance of turn motif labeling and basally restricted Miranda. (D-E) 
Quantification of apical/cytoplasmic and apical/basal ratios for the overexpressed 
proteins using HA average intensities. *** Represents a P-value < 0.0001. ns represents 
no significance. Mean and SEM are plotted. (F) Apical/cytoplasmic ratios of p-410 
labeling compared in aPKC FL and aPKC T422A overexpression. *** Represents a P-
value < 0.0001. Mean and SEM are plotted. (G-I) Positively marked GFP MARCM 
clones of FRTG13aPKCK06403. (G) FRTG13aPKCK06403 clone with mislocalized Miranda and 
no aPKC. (H) aPKC FL is able to rescue Miranda basal localization in FRTG13aPKCK06403 
null clones. (I) aPKC T422A is unable to rescue aPKC function in FRTG13aPKCK06403 
null clones and still localizes around the entire cortex.  
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cortex of mitotic neuroblasts, colocalizing with Miranda at the basal cortex (Figure 
2.4A). A small portion of metaphase neuroblasts showed reduced basal Miranda signal, 
consistent with aPKC T574A’s higher in vitro activity. The pT422 specific antibody 
yielded a signal similar to the uniform cortical localization of aPKC T574A indicating 
that the protein contains the activation segment modification (Figure 2.4A). These 
neuroblasts exhibited significantly lower staining of pT574, however, consistent with the 
inability of the transgenically expressed protein to be phosphorylated at this site, but also 
indicating an effect on the endogenous protein (Figure 2.4A’). The decrease in the apical 
pT574 likely results from competition of aPKC T574A with endogenous aPKC for 
binding to the apical cortex. Although T574A is more catalytically active than T422A, it 
is still unable to rescue positively marked aPKCk06403 clones, which may be due to its 
inability to be polarized (Figure 2.4F). These data demonstrate the necessity for turn 
motif phosphorylation in regulating aPKC’s activity and localization.  
Our results indicate that both the activation segment and turn motif must be 
phosphorylated for aPKC function during asymmetric cell division. Thus, the residual 
catalytic activity that proteins unphosphorylated at either of these sites possess is 
insufficient to polarize fate determinants, or the phosphorylations are necessary for 
activation of the autoinhibited conformation. Beyond their role in regulating aPKC 
activity, we have discovered that aPKC kinase domain phosphorylations are also 
important for aPKC polarity – if modification at either site is missing, aPKC is not 
restricted to the apical cortex. We also examined the localization of a commonly used 
“kinase dead” aPKC variant with a mutation in the ATP-binding pocket, K293W. This 
protein localized in a manner indistinguishable from the T422A and T574A proteins and 
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Figure 2.4.  aPKC turn motif and ATP binding mutants are inactive and mislocalize. 
(A-B and A’-B’) Inscuteable-GAL4 was used at 30°C and wandering third instar larvae 
were dissected. Anti-HA stains for the overexpressed protein, p-410 for the activation 
loop, p-560 for the turn motif, and Miranda. (A-A’) aPKC T574A showing complete 
cortical localization of the mutant protein with maintenance of activation loop labeling, 
reduced turn motif labeling, and basally restricted Miranda (B-B’) aPKC K293W 
showing complete cortical localization of the mutant protein with reduced activation loop 
labeling, maintained turn motif labeling, and abnormal Miranda labeling. (C and D) 
Quantification of apical/cytoplasmic and apical/basal ratios for the overexpressed 
proteins using HA average intensities. *** Represents a P-value < 0.0001. ** Represents 
a P-value < 0.01. ns represents no significance. Mean and SEM are plotted. (E) 
Apical/cytoplasmic ratios of p-410 labeling compared in aPKC FL, aPKC T574A, and 
aPKC K293W overexpression. *** Represents a P-value < 0.0001. ns represents no 
significance. Mean and SEM are plotted. (F-G) Positively marked GFP MARCM clones 
of FRTG13aPKCK06403. (H) aPKC T574A is unable to rescue FRTG13aPKCK06403 null clone 
mislocalization of Miranda, while still weakly localizing around the entire cortex. (I) 
aPKC K293W is unable to rescue FRTG13aPKCK06403 null clone mislocalization of 
Miranda, while still localizing around the entire cortex. 
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was also unable to rescue aPKCk06403 mutant neuroblasts (Figure 2.4B-B’ and G). In 
previous work, we found that the K293W mutation prevents phosphorylation of the T422 
site (and likely also the T574 site), which has been observed with other PKCs (Graybill et 
al., 2012). Together, these results indicate that the kinase domain modifications regulate 
aPKC localization either through their role in promoting catalytic activity, or through 
some other unknown function.  
 
Identification of a Par-independent aPKC cortical targeting mechanism 
Polarization of aPKC occurs through coordinated interactions with the other Par 
complex members Baz and Par-6, and the Rho GTPase Cdc42. The interaction between 
aPKC and Par-6 is via heterodimerization of their PB1 domains (Atwood et al., 2007; 
Hirano et al., 2004; Noda et al., 2003; Rolls et al., 2003; Wodarz et al., 2000), while Baz 
interacts with the aPKC kinase domain as it is a substrate (Atwood et al., 2007; Joberty et 
al., 2000; Lin et al., 2000). A fundamental question in cell polarity is how these 
interactions are coordinated to properly polarize aPKC, the key output of the Par 
complex. To assess the role of these additional interactions in the ectopic localization of 
aPKC variants that lack phosphorylation at the activation segment and/or turn motif, we 
examined the localization of Baz and Par-6 in neuroblasts expressing T422A or T574A 
aPKCs. Surprisingly, Baz and Par-6 localization were unaffected by either of these 
proteins (Figure 2.5), indicating that the ectopic localization of aPKCs lacking kinase 
domain modifications occurs without the other components of the Par complex. Thus, we 
have identified a mechanism that targets aPKC to the cortex that is independent of the 
protein-protein interactions typically thought to be required for cortical recruitment. 
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Figure 2.5. Kinase mutants localize around the cortex independent of other Par 
complex members. (A-E and A-E’) Inscuteable-Gal4 was used at 30°C and wandering 
third instar larvae were dissected. Anti-HA stains for the overexpressed protein. 
Neuroblasts were marked with Baz and Par-6. (A-E) Baz remains apically restricted 
regardless of mutant protein localization. (A’-E’) Par-6 remains apically restricted 
regardless of mutant protein localization. (F) Model showing the possible roles of the 
activation loop phosphorylation within aPKC by PDK1, in generation of polarity and 
self-renewal. 
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DISCUSSION 
We have found that PDK1 is necessary for proper development of the Drosophila 
central nervous system. Loss of PDK1 led to a reduction in neuroblast number, consistent 
with a defect in self-renewal. PDK1 has a known role as an upstream regulator of PKC 
family proteins, and we found that in neuroblasts lacking PDK1, aPKC had reduced 
activation segment phosphorylation. Surprisingly, however, aPKC was also mislocalized 
in the absence of PDK1 activity, targeting to the apical region, but also to the basal region 
where it colocalized with Miranda.  
PDK1 is the upstream activating kinase for many AGC protein family kinases 
including Protein Kinase Cs (PKCs) (Newton, 2010). PKC phosphorylation by PDK1 can 
be important for catalytic competence, although the role of this modification in aPKC 
activity has been unclear (Newton, 2010; Pearce et al., 2010). Although a single substrate 
concentration in vitro enzyme assay suggested that activation segment phosphorylation 
by PDK1 is necessary for aPKC activity, a co-complex structure of the aPKC catalytic 
domain and a peptide from Par-3 lacked the modification, indicating that it is not 
absolutely essential for substrate binding (Wang et al., 2012). Our comprehensive 
analysis of aPKC variants lacking both activation segment and turn motif 
phosphorylations demonstrates that full activity requires modification at these sites, but 
significant residual activity remains in their absence.   
Although the kinase domain phosphorylations are not absolutely required for 
catalytic activity, we have found that they are essential for aPKC function during 
neuroblast asymmetric cell division. Surprisingly, however, the modifications are not 
only essential for activity, as we see colocalization of the non-phosphorylatable aPKC 
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variants with Miranda, but for aPKC polarity. Apparently the phosphorylations normally 
prevent aPKC’s entry into the basal domain, either via their role in enhancing catalytic 
activity, or through another function. A kinase-dead version of aPKC is also unpolarized, 
although the mutation that prevents catalytic activity does so by disrupting ATP binding, 
which has been found to be required for phosphorylation of both the activation segment 
and turn motif (Cameron et al., 2009). Analysis of neuroblasts expressing aPKC variants 
that selectively abrogate activity or kinase domain modification will be required to 
uncover the precise role of these modifications in aPKC polarization. 
We found that much of the pdk1 phenotype was recapitulated by the 
unphosphorylatable aPKC variants, although it is possible that PDK1 is important for 
self-renewal via other pathways. This possibility is supported by our observation that 
self-renewal was defective in pdk1 RNAi neuroblasts even under conditions where 
sufficient aPKC activity remained for polarity. As PDK1 functions upstream of many 
other AGC protein kinases, one or more of these pathways could regulate self-renewal, 
potentially through a polarity-independent mechanism (Mora et al., 2004). The signaling 
pathways involved in maintaining stem-ness remain poorly understood and this system 
could be useful for uncovering this important aspect of stem cell function. 
 
BRIDGE TO CHAPTER III 
 In the previous chapter, I described a role for aPKC activation loop and turn motif 
phosphorylations in the regulation of activity and localization of aPKC during 
asymmetric cell division of Drosophila neuroblasts. During this investigation it became 
clear that aPKC is able to localize to the cortex independently of other Par complex 
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members. This suggested that aPKC is able to interact with the cortex without binding to 
Par-3 and Par-6, at least in some mutant contexts. This interaction could be through yet to 
be determined protein-protein interactions, or through protein-lipid interactions, not yet 
appreciated for aPKC.  In the following chapter, I describe how multiple domains within 
aPKC are working together in order to properly localize and activate aPKC. This 
mechanism involves the coordination between multiple protein-protein interactions, as 
well as a newly identified protein-lipid interaction. In the dividing Drosophila neuroblast, 
neither interaction is sufficient to localize or activate aPKC properly, indicating that 
protein-protein and protein-lipid interactions are required to properly generate polarity of 
aPKC.  
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CHAPTER III 
LIPID AND PROTEIN INTERACTIONS COORDINATE LOCALIZATION AND 
ACTIVITY OF ATYPICAL PROTEIN KINASE C (APKC) DURING 
ASYMMETRIC CELL DIVISION  
This chapter contains unpublished co-authored material 
Author contributions: Michael Drummond, Scott X. Atwood, and Kenneth Prehoda 
designed the research; Michael Drummond and Scott X. Atwood performed the research; 
Michael Drummond, Scott X. Atwood and Kenneth Prehoda analyzed the data; and 
Michael Drummond, Scott X. Atwood and Kenneth Prehoda wrote the manuscript. 
 
INTRODUCTION 
Generation of molecularly distinct regions of a cell, cell polarity, is required for 
diverse processes such as cell migration, maintenance of tissue homeostasis, and 
regulation of cell fate decisions.  Stem cells generate cell polarity to divide 
asymmetrically, separating proteins specifying proliferation from those involved in 
differentiation. This ensures that the stem cell will self-renew, a hallmark of all stem 
cells, and also give rise to a daughter cell that is able to differentiate into all other 
necessary cell types. Proper maintenance of this asymmetric division is essential for early 
development, as well as avoiding overproliferation that can lead to tumor-like phenotypes 
(Doe, 2008; Homem and Knoblich, 2012; Prehoda, 2009) 
The Par complex consisting of Bazooka (Baz; Par-3), Cdc42, Par-6, and the 
serine/threonine kinase, atypical kinase C (aPKC), is essential for the establishment and 
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maintenance of the above-mentioned diverse polarities. In the C. elegans zygote, where 
these proteins were first discovered, this complex is localized to the anterior side of the 
cell and differentially partitions developmental factors during the first cell division 
(Kemphues et al., 1988; Suzuki and Ohno, 2006).  Drosophila neural stem cells, referred 
to as neuroblasts (NBs), dynamically regulate the polarity of the Par complex during 
mitosis to ensure self-renewal and segregation of fate determinants to daughter cells. This 
is in contrast to epithelial cells, which maintain Par complex polarization throughout the 
cell cycle to preserve cellular architectures. Loss of Par complex localization in any of 
the aforementioned systems is detrimental to proper development and cellular 
homeostasis (Homem and Knoblich, 2012; Suzuki and Ohno, 2006; Tepass, 2012).  
The Par complex mediates establishment of polarity by cortical exclusion, 
specifically through the kinase activity of aPKC (Atwood and Prehoda, 2009; 
Betschinger et al., 2003; Haenfler et al., 2012; Smith et al., 2007). In NBs, aPKC and 
Miranda (Mira) are localized to opposing sides of the cell. Mira is a scaffold protein for 
the fate determinant proteins, Brain tumor (Brat) and Prospero (Pros) that direct cellular 
differentiation (Doe et al., 1991; Ikeshima-Kataoka et al., 1997; Lee et al., 2006c). Upon 
division, the Par complex is localized to the apical side and prevents apical localization of 
Mira via phosphorylation (Atwood and Prehoda, 2009). This results in a self-renewed 
mother cell and a ganglion mother cell (GMC) that differentiates to populate the central 
nervous system with neurons and glia (Doe, 2008; Sousa-Nunes and Somers, 2013). This 
mechanism of polarization is not specific to Mira. The neoplastic tumor suppressor lethal 
giant larvae (Lgl) and a Notch regulator, Numb, are spatially regulated by aPKC in a 
similar manner (Betschinger et al., 2003; Smith et al., 2007).  
  
 
43 
Spatial regulation of aPKC is crucial for proper organism development, 
prevention of tissue disorganization, and overproliferation, yet the mechanisms that 
regulate its activity and localization remain unclear. Mutations in genes required for 
proper aPKC polarization are detrimental to organism survival. An intensely studied 
example is Lgl. In the developing central nervous system (CNS) of Drosophila, lgl loss 
of function mutants do not faithfully restrict aPKC to the apical cortex, resulting in extra 
NBs (Lee et al., 2006b). The same phenotype, albeit more dramatic, is observed when a 
constitutively active cortical aPKC (aPKC-CAAX) is overexpressed, causing fate 
determinants carried by Mira, and Numb to localize aberrantly, ultimately resulting in 
overproliferation of NBs (Haenfler et al., 2012; Lee et al., 2006b). These results 
demonstrate the necessity of spatially regulating aPKC, but mechanistic details of aPKC 
polarization are unclear.  
Genetic and biochemical data have demonstrated that Baz is likely the first 
member of the complex to be localized to the apical cortex of embryonic NBs (Kuchinke 
et al., 1998). aPKC and Par-6 act downstream of Baz, since aPKC and Par-6 mutants do 
not disrupt Baz apical restriction in NBs (Kuchinke et al., 1998; Petronczki and Knoblich, 
2001; Rolls et al., 2003).  Next, Cdc42 is either recruited or activated at the same location 
(Atwood et al., 2007). Par-6 interacts with Cdc42 allowing for aPKC polarization though 
heterodimerization of aPKC’s and Par-6’s PB1 domains (Atwood et al., 2007; Garrard et 
al., 2003; Noda et al., 2003). This would suggest that aPKC is polarized through its 
interaction with the Par-6 PB1 domain, but no functional role in polarization for other 
domains within aPKC is reported.  
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Here we examine the mechanism that regulates aPKC localization by determining 
the domains within aPKC required for localization and kinase activity, using Drosophila 
NBs as a model. We were able to determine that a simple model suggesting that the PB1-
PB1 interaction between aPKC and Par-6 is insufficient to explain aPKC polarization. 
Instead, aPKC requires coordinated interactions between Cdc42, Par-6, and direct cortical 
binding of the C1 domain. We found that disrupting any of these interactions individually 
led to mislocalization of aPKC, and in some cases, Par-6 and Mira, during asymmetric 
cell division of NBs. This led us to propose a model where the localization mechanism of 
aPKC is coupled to its activation, and uncoupling them leads to fate determinant 
segregation defects. 
 
MATERIALS AND METHODS 
Fly strains and genetics 
W1118 (wild type), inscutable-GAL4 (Doe Lab), UAS-HA:Par-6 FL, UAS-HA:Par-
6 ISAA (Atwood et al., 2007), UAS-HA:aPKC ΔPB1 (107-606), UAS-HA:aPKC PB1 (1-
111), UAS-HA:aPKC ΔPB1PS (139-606), UAS-HA:aPKC ΔC1 (lacking 141-196), UAS-
HA:aPKC RD (1-195), UAS-HA:aPKC C1 (139-195), UAS-HA:aPKC FL (1-606), UAS-
HA:aPKC D63A, UAS-HA:aPKC ΔPDZL (1-600), (this study). Stocks were balanced 
over TM3, Sb. To produce UAS-HA:aPKC transgenic animals, we PCR amplified and 
subcloned the coding sequence into pUAST-attp vectors downstream of a 5’ 
hemagglutinin (HA) tag and generated transformants using standard injection methods 
(Genetic Services). Wild type and UAS expressed larvae (inscuteable-GAL4) were aged 
at 30˚C until the wandering third instar larval stage.  
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MARCM clones were generated as previously described (Lee and Luo, 1999). In 
brief, FRTG13aPKCk06403/Cyo were crossed to ;;UAS-aPKC FL, ;;UAS-HA:aPKC PB1, 
and ;;UAS-HA:aPKC ΔC1 flies. F1s males lacking Cyo were collected and crossed to 
virgin elav-GAL4, UAS-mCD8:GFP, hs:flp ; FRTG13, tubPGal80  (Doe Lab). Larvae 
were heat shocked 24 hours after larval hatching at 37°C for 90 minutes and again 10-16 
hours after the first heat shock. Larvae were allowed to grow to the wandering third instar 
larval stage at 22°C or 25°C and then dissected and immunostained. aPKC null clones 
were positively marked with GFP and the presence of the mutant aPKC was visualized by 
staining for HA.  
 
Antibodies and immunostaining 
We fixed and stained larval brains as previously described (Atwood and Prehoda, 
2009). Primary antibodies used in this study included: rabbit anti-PKCζ (C20; 1:1000; 
Santa Cruz Biotechnology Inc), rat anti-Par-6 (1:1000) (Rolls et al., 2003), guinea pig 
anti-Mira (1:500) (Gift from the Doe Lab) rat anti-Mira (1:500) (Gift from the Doe Lab), 
rabbit anti-Phospho-Histone H3 (1:10,000; Santa Cruz), guinea pig anti-Baz (1:1000) 
(Gift from the Doe Lab), mouse anti-HA (1:500; Covance), rat anti-Deadpan (Gift from 
the Doe Lab), Chicken anti-GFP (1:5000; ab13970, Abcam). Secondary antibodies were 
from Jackson ImmunoResearch Laboratories and Invitrogen. Confocal images were 
collected using a Zeiss 700 equipped with 40x oil immersion objective/1.43 NA or an 
Olympus Fluorview 1000 equipped with a 40x oil immersion objective/1.30 NA. Figures 
were generated using Fiji, Adobe Photoshop, and Adobe Illustrator. Quantifications were 
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done using Graphpad Prism. For comparisons of apical/cytoplasmic ratios, we used a 
two-tailed unpaired t-test. 
 
Protein purification and binding experiments 
All GST and His tagged proteins were expressed and purified, as previously 
described (Atwood et al., 2007). All MBP-tagged proteins were purified, as described 
(Graybill et al., 2012). Drosophila embryonic lysate were prepared, as previously 
described (Atwood et al., 2007). Yeast two-hybrid assays were performed by cloning 
constructs into pGBK and pGAD plasmids and transfecting into yeast strain AH109. 
Yeast were plated onto SD(-LEU)(-TRP) and SD(-HIS)(-LEU)(-TRP) plates, incubated 
at 30°C for 96 hours, and assayed for growth. 
 
Giant unilamellar vesicle production 
All lipids were purchased from Avanti Polar Lipids. Lipids used in this study: L-
a-phosphatidylcholine (840051C), L-a-phosphatidylserine (840032), L-a-
phosphatidylinositol-4-phosphate (840045X), L-a-phosphatidylglycerol (840101C), and 
L-a-phosphatidic acid. Giant unilamellar vesicles (GUVs) were prepared as previously 
described (Moscho et al., 1996). In brief, lipids were added to 500 ml of chloroform in a 
round bottom flash and spun at 150 rpms in a 50°C for 2 minutes. Chloroform was 
removed by rotovap and placed in a vacuum chamber for 15 minutes. Lipids were then 
resuspended in 0.2 M sucrose at 0.5 mg/ml and incubated in a 50°C water bath for 4-16 
hours. After incubation, GUVs were placed at 4°C for storage for up to 5 days. 
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Lipid binding cosedimentation assay 
Cosedimentation was carried out by methods previously described (Prehoda et al., 
2000). In brief, proteins were clarified by a pre-spin at 100,000 x g for 30 minutes using a 
TLA-100 at 10 C. Next, a final concentration of 5 µM protein was incubated with GUVs 
containing 0.23 mg/ml lipids in assay buffer (20 mM HEPES, pH 7.0, 50 mM NaCl, 1 
mM DTT) and allowed to incubate for 10 minutes at room temperature. The reaction was 
then spun at 100,000 x g for 60 minutes using a TLA-100 rotor at 10°C. Supernatants 
were completely removed and saved for SDS-PAGE analysis. Pellets were resuspended 
in assay buffer and saved for SDS-PAGE analysis. All samples were run on 12.5% SDS 
PAGE gels and subsequently stained with coomassie. Gels were imaged with a scanner.  
RESULTS 
The aPKC PB1 domain is required but not sufficient for aPKC polarization 
According to the current model, aPKC’s PB1 domain is sufficient for polarization 
through heterodimerization with Par-6’s PB1 domain and subsequent recruitment to the 
apical cortex through the small GTPase Cdc42 (Atwood et al., 2007; Noda et al., 2003; 
Prehoda, 2009). This model lacked functional details of the role other aPKC domains 
play in polarization, and in general lacked mechanistic details of how aPKC polarization 
occurs. Given the importance of aPKC in the generation and maintenance of polarity, we 
sought to understand the mechanistic details by which this occurs. 
  In order to dissect the underlying mechanism responsible for aPKC polarization, 
we performed an in vivo structure function study using Drosophila NBs. We were 
specifically interested in mitotic NBs, since this is the point in the cell cycle when 
polarity is generated. To accomplish this, we generated transgenic Drosophila that 
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contained the full-length protein (aPKC FL), the PB1 domain alone (aPKC PB1), or the 
deletion of the PB1 domain (aPKC ΔPB1) under the control of the UAS-GAL4 system 
(Figure 3.1A). These were injected into the same chromosomal location (attp2) and each 
contained an NH2-terminal hemagglutinin (HA) tag. Localization of all of the 
overexpressed transgenes was visualized by HA staining. In order to make conclusions 
about the role of individual domains within aPKC, we first determined if overexpressed 
full-length protein localized correctly. When we drove expression of aPKC FL in NBs 
using inscuteable-GAL4, we observed aPKC FL polarized to the apical cortex in a wild 
type manner without causing any dominant phenotypes throughout the cell cycle (Figure 
3.1B, 3.1B’, and data not shown). For quantification purposes, we measured the 
enrichment at the apical cortex, using a ratio of apical to cytoplasmic intensities of the 
HA antibody stains, during metaphase, for the overexpressed proteins (Figure 3.1F). This 
allowed us to unambiguously distinguish between apical enrichment and cytoplasmic 
localization. Next, we determined if our aPKC FL allele was able to rescue aPKC loss of 
function (LOF) phenotypes within aPKC LOF clones, where Mira is no longer restricted 
to the basal domain of mitotic NBs. This approach allows us to make conclusions about 
how our overexpressed proteins are functioning in the absence of endogenous aPKC. Our 
aPKC FL rescued the restriction of Mira to the basal cortex (Figure 3.1H). Since aPKC 
FL localized as expected and was able to rescue Mira localization in our LOF clone 
analysis, we determined that we would be able to test the current model of aPKC 
polarization using our transgenic flies.   
To test the sufficiency of the PB1 domain, we overexpressed aPKC PB1 in NBs. 
We observed cytoplasmic localization of aPKC PB1 (Figure 3.1C), suggesting that 
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aPKC’s PB1 domain is not sufficient for polarization. We did not observe any defects in 
endogenous Par-6 or Mira (Figure 3.1C and C’), suggesting that endogenous proteins 
were properly functioning, and our PB1 overexpression was not causing any noticeable 
dominant phenotypes. Since aPKC and Par-6 PB1 domains are sufficient to interact in 
vitro (Noda et al., 2003), it was possible that the endogenous aPKC bound to Par-6 with 
higher affinity, which was leading the overexpressed PB1 domain to localize in the 
cytoplasm. To verify that the PB1 domain was not sufficient for polarization, we assessed 
the localization of aPKC PB1 in aPKC LOF clones. Overexpressed aPKC PB1 localized 
to the cytoplasm in this genetic background, verifying that it is not sufficient for aPKC 
polarization (Figure 3.1I). 
Next, we tested the requirement of the aPKC PB1 domain. We removed the PB1 
domain from aPKC (aPKC ΔPB1) and investigated the localization as described above.  
Although the current model predicts that aPKC lacking its PB1 domain would localize to 
the cytoplasm due to it being the only know interaction it has with Par-6, it localized 
around the entire cortex in mitotic NBs (Figure 3.1D). This localization was independent 
of Par-6, as Par-6 maintains apical localization (Figure 3.1D’). These data suggest a 
general cortical signal exists within aPKC, outside of its PB1 domain. This localization 
signal is likely independent of aPKC’s interactions with Par-6, since Par-6 remains 
apically localized. The observation that aPKC ΔPB1 domain localized around the entire 
cortex also implies that aPKC’s PB1 domain could be suppressing an unidentified 
cortical targeting domain within aPKC. These data also reiterate that aPKC’s interaction 
with Par-6 through their PB1 domains, while not sufficient, is necessary for apical 
polarization.  
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aPKC’s PB1 domain is required for aPKC activation  
Precise control of aPKC’s kinase activity is required to ensure proper 
development, as well as prevention of tumorigenic overproliferation (Guyer and Macara, 
2015; Lee et al., 2006b) aPKC’s pseudosubstrate (PS) motif binds to the active site to 
prevent ectopic kinase activity, until needed (Newton, 2010). It has recently been 
demonstrated in vitro, that binding of Par-6 activates aPKC through displacement of its 
PS (Graybill et al., 2012).  In organisms lacking aPKC or expressing an 
unphosphorylatable Mira, Mira localizes around the entire cortex (Atwood and Prehoda, 
2009). This demonstrates that aPKC phosphorylation is required to restrict Mira to the 
basal cortex of mitotic NBs. We compared the localization of Mira in brains 
overexpressing aPKC ΔPB1 versus aPKC lacking the PB1 and PS (aPKC ΔPB1PS) in 
mitotic NBs to investigate the role of the aPKC PB1 domain and PS in activity.  
___________________________________________ 
Figure 3.1 (next page). aPKC’s PB1 domain is required but not sufficient for 
polarization. (A) Cartoon depiction of aPKC domain architecture, showing a 
representation of the mutant transgenes overexpressed in this panel. (B-E) Mitotic larval 
neuroblast overexpressing the indicated transgenes using inscuteable-GAL4 labeled with 
aPKC/PH3, Miranda and HA. HA represents the localization of the overexpressed 
proteins. Anti-aPKC also stains any overexpressed protein that contains the kinase 
domain. Scale bars represent 5 µm. (B’-E’) Par-6 stains are from separate neuroblasts 
overexpressing the indicated mutant protein (B-B’) aPKC FL showing apical localization 
with wild type Miranda and Par-6. (C-C’) aPKC PB1 showing cytoplasmic localization of 
the mutant protein with wild type Miranda and Par-6. (D-D’) aPKC ΔPB1 localizing 
around the entire cortex. Miranda and Par-6 maintain their wild type localization. (E-E’) 
aPKC ΔPB1PS localizing around the entire cortex with displaced Miranda and wild type 
Par-6 labeling. (F) Apical/cytoplasmic intensity ratios for each of the overexpressed 
proteins labeled by HA, compared to overexpression of aPKC FL. The mean and SEM 
are plotted.  *** p-value < 0.0001, ** p-value = 0.0031, and * p-value = 0.0135 (G-I) 
aPKC LOF clones positively marked with GFP, labeled with Miranda and HA, 
expressing the indicated transgene. (G) No aPKC expression with Miranda around the 
entire cortex. (H) aPKC FL overexpression rescues basal restriction of Miranda. (I) aPKC 
PB1 domain localizes in the cytoplasm of aPKC LOF clones. 
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Psuedosubstrates are known to play a role in repressing kinase activity of PKC 
family proteins (Newton, 2010). Therefore we predicted that removal of the PB1 through 
the PS had two likely outcomes. The PS could be required for both, cortical targeting and 
activity inhibition, leading to the overexpressed protein being active in the cytoplasm, or 
the PS is only required for kinase activity regulation, therefore it would localize around 
the entire cortex while being active. Ectopically expressed aPKC ΔPB1 co-localizes with 
Mira at the basal cortex (Figure 3.1D). The lack of Mira displacement by aPKC ΔPB1 
demonstrates that the protein is inactive in the basal domain, even though it is bound to 
the cortex. Since aPKC ΔPB1 is cortical but inactive, this suggests that cortical binding 
may not be sufficient for aPKC activation in mitotic NBs. Consistently, the removal of 
the PB1 alone is not sufficient to activate aPKC in vitro (Graybill et al., 2012). Similar to 
aPKC ΔPB1, aPKC ΔPB1PS localized around the entire cortex, Par-6 remained apical, 
but Mira localized exclusively to the cytoplasm (Figure 3.1E and 3.1E’). This 
demonstrates that aPKC ΔPB1PS is active in the basal domain and likely along the entire 
cortex. This suggests that the PS is required to represses ectopic kinase activity, but it is 
not required for general cortical targeting. Further supporting this, we also observed a 
dramatic increase in NBs (100 vs  >1000 per lobe, data not shown) consistent with aPKC 
ΔPB1PS being an active kinase. These data revealed that the PB1 domain of aPKC is 
required for both apical restriction of aPKC and activation in vivo, likely through Par-6 
PB1 domain interaction. 
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The aPKC C1 domain is a cortical targeting signal 
The cytoplasmic localization of aPKC PB1 and complete cortical localization of 
aPKC ΔPB1 indicated the presence of a cortical targeting signal within aPKC outside of 
the PB1 domain. In order to determine which domain(s) could be playing a role in 
cortical targeting, we removed candidate domains. We hypothesized that the C1 domain 
of aPKC was an excellent candidate.  In canonical PKCs, C1 domains play an important 
role in membrane targeting and activation through binding of diacyglycerol (DAG) and 
phorbol esters (Newton, 2010). However, aPKC contains four arginine residues within its 
C1 domain, that render it insensitive to DAG (Pu et al., 2006). If the C1 domain of aPKC 
plays a role in localization, we expected that its removal would lead to cytoplasmic 
localization of aPKC.  
When we overexpressed aPKC lacking its C1 domain (aPKC ΔC1) in NBs, 
cytoplasmic localization of the overexpressed protein was observed (Figure 3.2B). 
Endogenous Par-6 maintained wild type localization, while Mira showed enhanced 
cytoplasmic localization (Figure 3.2B and 3.2B’). These results are consistent with the 
previously described function of the C1 domain in playing a role in the regulation of 
aPKC kinase activity (Graybill et al., 2012; Lopez-Garcia et al., 2011). The same 
localization was observed for aPKC ΔC1 and Mira in aPKC LOF clones overexpressing 
aPKC ΔC1, verifying its importance (Figure 3.2H).  
The cytoplasmic localization aPKC ΔC1 made the C1 domain a good candidate 
for cortical binding. To rigorously test this, we took advantage of a previously described 
aPKC allele in which the NH2-terminal portion of the protein, through the C1 domain, is 
deleted (aPKC ΔN) (Lee et al., 2006b) and two new alleles, one that expresses the 
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regulatory  domains in the NH2-terminus of aPKC containing the PB1 through the C1 
domain (aPKC RD) and the C1 domain alone (aPKC C1) (Figure 3.2A). When 
overexpressed, aPKC ΔN localized to the cytoplasm, while aPKC RD localized around 
the entire cortex of NBs (Figure 3.2C and 3.2D).  Par-6 and Mira were undisturbed in 
aPKC RD expressing NBs (Figure 3.2C and 3.2C’), whereas Mira was displaced in aPKC 
ΔN expressing NBs, as previously reported (Lee et al., 2006b) (Figure 3.2D). Combining 
the data from these two constructs, we conclude that the C1 domain is likely responsible 
for general cortical targeting of aPKC. Out of the constructs tested thus far, all containing 
the C1 domain localized to the cortex, either apically or completely cortical, whereas any 
construct lacking the C1 domain localized to the cytoplasm. In order to verify the C1  
___________________________________________ 
Figure 3.2 (next page). The C1 domain of aPKC is a general lipid binding domain 
required for aPKC cortical localization. (A) Cartoon depiction of aPKC domain 
architecture, showing a representation of the mutant transgenes overexpressed in this 
panel. (B-E) Mitotic larval neuroblast overexpressing the indicated transgenes using 
inscuteable-GAL4 labeled with aPKC/PH3, Miranda, and HA. Scale bars represent 5 µm.  
(B’-C’) Par-6 stains are from separate neuroblasts overexpressing the indicated mutant 
transgene (B-B’) aPKC ΔC1 localized to the cytoplasm with Miranda mostly displaced to 
the cytoplasm while Par-6 maintains wild type localization. (C-C’) aPKC RD localized 
completely around the cortex with wild type Miranda and Par-6 localization. (D) aPKC 
ΔN localized to the cytoplasm and Miranda is displaced. (E) aPKC C1 localized to the 
entire cortex with wild type Miranda labeling. (F) Apical/cytoplasmic intensity ratios for 
each of the overexpressed proteins labeled by HA compared to overexpression of aPKC 
FL. ***p-value < 0.0001, **p-value = 0.0028, and ns is not significant. The mean and 
SEM are plotted. (G and H) aPKC LOF clones positively marked with GFP, labeled with 
Miranda, and HA while overexpressing the indicated transgene. (G) No aPKC expression 
with Miranda around the entire cortex. (H) aPKC ΔC1 localizes to the cytoplasm and 
Miranda is displaced into the cytoplasm. (I) Purified MBP:C1 domain binds to 
phosphatidylglycerol (PG), phosphatidylcholine (PC), phosphatidylserine, and 
phosphatidic acid (PA) in a lipid cosedimentation assay while MBP does not. S 
represents the supernatant, the unbound fraction, while P represents the pellet, the bound 
fraction. No lipid indicates the absence of liposomes in the reaction mixture. 
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domain role in cortical targeting, we tested the localization of aPKC C1. Overexpressed 
aPKC C1 in NBs localized around the entire cortex, demonstrating that it is sufficient for 
cortical binding but not polarization (Figure 3.2E). We conclude that the C1 is a general 
cortical targeting domain. 
The aPKC C1 domain binds directly, but non-specifically, to phospholipids 
Next, we sought to determine what the C1 domain of aPKC binds to at the cortex. 
C1 domains are common among PKC family members, most binding to DAG and 
phorbyl esters to help localize and activate the proteins (Newton, 2010). We hypothesized 
that the C1 domain would bind to phospholipids. This was tested by using purified 
MBP:C1 domain  in a liposome co-sedimentation assay. We generated giant unilamellar 
vesicles (GUVs) with 100% phosphatidyserine (PS), phosphatidycholine (PC), 
phosphotidylglycerol (PG), or phosphatidic acid (PA). When we tested the C1 domain for 
binding with phospholipids, we discovered that the domain bound to all lipids tested in 
the GUV assay, while MBP bound to none of the liposomes (Figure 3.2I). This suggests 
that C1 domain is a general lipid binding domain. This is consistent with the C1 
localizing around the entire cortex of Drosophila NBs when overexpressed. From these 
data, we conclude that aPKC’s C1 domain is able to non-specifically bind to the entire 
cortex through direct phospholipid interactions.  
aPKC NH2- and COOH-termini intramolecularly interact with one another 
aPKC RD and aPKC ΔPB1PS revealed that both the NH2 and COOH ends of 
aPKC are required to suppress the general cortical targeting by the C1 domain, as 
removal of either led to complete cortical localization of the mutant proteins. In order to 
restrict this localization, we hypothesized that aPKC is in a conformation in which the C1 
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cortical targeting ability is suppressed until interaction with regulatory proteins occurs. 
This suggested that aPKC could have intramolecular interactions that prevent ectopic 
localization and activation of aPKC until it interacts with Par-6. This is true for other 
PKC family members. The crystal structures of PKCiota, PKCbeta, and PKCepsilon 
revealed that the COOH-terminus is able to interact with various regions within each 
protein (Kheifets and Mochly-Rosen, 2007; Messerschmidt et al., 2005). In order to 
investigate this possibility, we performed yeast two-hybrid assay using the COOH-
terminal end of aPKC (533-606) to search for intramolecular interactions. In this analysis, 
we found that any construct that contained the PB1 domain or PS interacted with the 
COOH-terminal aPKC fragment (3.3A). The interaction was the strongest with constructs 
that contained both the PB1 and PS. We verified these results with purified components. 
GST:aPKC 533-606 bound to GFP:aPKC 28-113 but not to GFP:aPKC 259-606 ( Figure 
3.3B). This interaction also occurs in the full-length protein as GST:aPKC 533-606 
interacts with aPKC 1-600, in which the intramolecular interaction should be disrupted, 
but not with the full-length protein (Figure 3.3C). We conclude that aPKC intramolecular 
interactions keep it in an inactive state until it binds the regulator proteins, Par-6 and 
Cdc42.  
 
aPKC contains a PDZ ligand that binds Par-6 in the presence of Cdc42 
We next sought to determine how Par-6 and Cdc42 regulate the intramolecular 
interactions within aPKC. We predicted that Par-6 binding should disrupt aPKC’s 
intramolecular interactions. This disruption should be required to generate the polarity  
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Figure 3.3. The NH2- and COOH-termini of aPKC intramolecularly interact 
(A) Yeast two-hybrid assay using aPKC 533-606 shows interaction with all constructs 
containing the PB1 domain (28-113) and the PS motif (120-141). A more robust 
interaction is observed when both the PB1 and PS domains are expressed together. (B) 
Western blot showing GST:aPKC 533-606 is able to bind aPKC PB1 but not the kinase 
domain (259-606) in vitro. (C) Western blot showing GST:aPKC 533-606 is able to bind 
aPKC with the intramolecular interaction disrupted (1-600) but not an aPKC where the 
intramolecular interaction is intact (wild-type 1-606). 
 
and activate aPKC as previously observed in vitro (Graybill et al., 2012). To test this we 
bound GST: aPKC 533-606 to aPKC 1-600 and asked if Par-6 could disrupt this 
interaction. Indeed, Par-6 was able to disrupt the interaction, suggesting that it is able to 
disrupt the aPKC intramolecular interaction (Figure 3.4A). We next sought to determine 
if aPKC contained a conserved motif at its COOH-terminus that could aid in predicting 
what it may be binding. Upon alignment of aPKC’s COOH-terminus with its human 
aPKC homologues and PKCalpha, we uncovered a conserved COOH-terminal valine, 
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which is a defining characteristic of COOH-terminal PDZ ligands (-D/E/K/R-X-φ-
COOH; where φ = hydrophobic residue) (Figure 3.4B).  
Since Par-6 contains a PDZ domain, we hypothesized it was a good candidate to 
bind aPKC’s PDZ ligand. We tested this using pull-down experiments between 
GST:aPKC 533-606 that includes the PDZ ligand, and Par-6 lacking its PB1 domain (Par-
6 CRIB-PDZ), since it is already known to dimerize with aPKC PB1 domain. GST:aPKC 
533-606 was unable to pull-down Par-6 CRIB-PDZ (Figure 3.4C). We rationalized that 
interaction might require Cdc42, because it has been previously reported that Cdc42 can 
induce Par-6 binding to COOH-terminal PDZ ligands with higher affinity than on its own 
(Penkert et al., 2004; Peterson et al., 2004). Upon addition of Cdc42•GTPγS to our 
binding reaction, we observed Par-6 bound to the COOH-terminus of aPKC (Figure 
3.4C). This suggests that Cdc42 promotes binding between Par-6 PDZ and the PDZ 
ligand of aPKC. This interaction likely occurs in vivo as well, as GST:Par-6 CRIB-PDZ 
was able to pull down aPKC from embryonic lysates supplemented with Cdc42•GTPγS 
(Figure 3.4D). This suggests a model in which aPKC, Par-6, and Cdc42 require 
coordinated interactions to form a complex. These interactions include, but may not be 
limited to, the PB1-PB1 interaction of Par-6 and aPKC, and a PDZ-PDZ ligand 
interaction between aPKC and Par-6, which requires GTP bound Cdc42.  
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Figure 3.4. Par-6 regulates aPKC’s intramolecular interaction and binds aPKC’s 
PDZ ligand in a Cdc42 dependent manner. (A) Western blot demonstrating that Par-6 
inhibits the interaction between GST:aPKC 533-606 and aPKC 1-600. (B) Alignment of 
Drosophila aPKC with human aPKCs and PKC alpha. (C) Western blot of GST:aPKC 
533-606 interacting with Par-6 CRIB-PDZ in a Cdc42-dependent manner. (D) Western 
blot showing Par-6 CRIB-PDZ interacting with endogenous aPKC in a Cdc42-dependnet 
manner in embryonic lysates. 
 
Interaction between aPKC PDZ ligand and Par-6 PDZ is required for proper  
 
polarity in neuroblasts 
 
Next we sought to determine the importance of these interactions for generating 
polarity during NB divisions. In order to accomplish this, we generated an allele that 
blocked the PB1-PB1 dimerization of aPKC and Par-6, but did not activate the C1 
domains cortical targeting observed when we completely removed the PB1 domain. To 
do this, we generated a transgenic line expressing an HA-tagged aPKC with a point 
mutation in aPKC’s PB1 domain, D63A, that is known to inhibit Par-6 and aPKC PB1 
dimerization (Hirano et al., 2004; Noda et al., 2003) (Figure 3.5A). When we 
overexpressed this protein in NBs, aPKC D63A localized to the cytoplasm without 
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disrupting Par-6 or Mira localization (Figure 3.5B and 3.5B’). This reiterates that PB1-
PB1 interaction between aPKC and Par-6 is required to allow for aPKC localization to 
the apical cortex and could be required for PDZ-PDZ ligand interaction between aPKC 
and Par-6.  This also suggests that the PB1-PB1 binding between aPKC and Par-6 is 
likely required to allow for C1 cortical targeting.  
In order to test the requirement of PDZ-PDZ ligand interaction, we generated a 
transgenic line to express aPKC lacking its PDZ ligand (aPKC ΔPDZL). This 
overexpressed allele localized to the cytoplasm, indicating that the PDZ-PDZ ligand 
interaction is required for proper aPKC localization (Figure 3.5C). Overexpression of this 
allele also led to endogenous Par-6 localizing to the cytoplasm and Mira localizing 
around the entire cortex (Figure 3.5C and 3.5C’). This indicated that the PDZ-PDZ ligand 
interaction between aPKC and Par-6 is required to generate polarity, likely though an 
induced conformational change induced by Cdc42 binding. Since the PDZ-PDZ ligand 
interaction requires the presence of Cdc42 in vitro, we tested this in NBs as well. In order 
___________________________________________ 
Figure 3.5 (next page). The PDZ ligand-PDZ interaction between aPKC and Par-6 
governed by Cdc42 is required for neuroblast polarity. (A) Cartoon depiction of 
aPKC domain architecture, showing a representation of the mutant transgenes 
overexpressed in this panel. Red asterisks represent point mutations. (B-E) Mitotic larval 
neuroblast overexpressing the indicated transgenes using inscuteable-GAL4 labeled with 
aPKC/PH3 or aPKC alone, Miranda, and HA. Scale bars represent 5 µm. (B-B’) aPKC 
D63A localized to the cytoplasm and no defects were observed in Par-6 or Miranda 
localization. (C-C’) aPKC ΔPDZL localized to the cytoplasm. Par-6 apical crescents are 
severely reduced and Miranda is uniformly cortical. (D) Par-6 FL localized apically and 
did not disrupt aPKC or Miranda staining. (E) Par6 ISAA localized to the cytoplasm. 
aPKC crescents were severely reduced and Miranda localization extended around the 
cortex.  (F) Apical/cytoplasmic intensity ratios for each of the ectopically expressed 
proteins labeled by HA compared to overexpression of aPKC FL. *** p-value < 0.0001. 
The mean and SEM are plotted. (G) Apical/cytoplasmic intensity ratios for Par-6 FL 
versus Par6 ISAA HA signal. *** p-value < 0.0001. The mean and SEM are plotted. (H) 
Proposed model of aPKC polarization during asymmetric cell division of Drosophila 
neuroblasts. 
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to test this, we used previously described alleles, a full-length HA-tagged Par-6 (Par-6 
FL) and a HA-tagged Par-6 ISAA, which has mutations in the ‘Semi-CRIB’ preventing 
its binding to Cdc42 (Atwood et al., 2007). Overexpressed Par-6 FL localized apically, as 
seen by HA staining, while aPKC remained robustly apical with polarized Mira (Figure 
3.5D). Overexpressed Par-6 ISAA localized cytoplasmically in dividing NBs (Figure 
3.5E). Overexpression of Par-6 ISAA also led to Mira ectopically localizing around the 
entire cortex and a concomitant reduction in aPKC apical staining (Figure 3.5E). This 
indicates that Par-6 must interact with Cdc42 in order to get aPKC to the cortex. We 
conclude that Par-6 and aPKC need to interact through both, PB1-PB1 
heterodimerization, as well as, PDZ-PDZ ligand interaction, which require Cdc42 
binding of Par-6. These interactions are necessary to restrict aPKC C1 domain cortical 
targeting to the apical cortex. Disruption of any of these interactions is sufficient to 
perturb polarity, and therefore, they must be tightly regulated.  
DISCUSSION 
aPKC is essential for the generation and maintenance of several cellular polarities, 
which are crucial to proper development and disease prevention. These diverse polarities 
require aPKC kinase activity to be restricted to specific areas of the cell. Moreover, loss 
of aPKC regulation can lead to premature loss of neural stem cells or disease states, such 
as cancer. Despite the overall importance of aPKC during development, the mechanism 
by which aPKC activity is spatially regulated remained poorly understood.  Here, we 
demonstrate that the aPKC PB1-PB1 interaction Par-6, while required for apical 
localization in NBs, is not sufficient to explain how aPKC becomes polarized. Instead, 
aPKC polarization requires the precise regulation both inter- and intramolecular, protein-
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protein interactions, as well as protein-lipid interactions. We were able to demonstrate 
that aPKC’s NH2- and COOH-termini interact. This intramolecular interaction is needed 
to suppress the complete cortical targeting activity of the aPKC C1 domain binding of 
phospholipids. In order to break aPKC’s intramolecular interaction, Par-6 dimerizes with 
aPKC through PB1-PB1 interactions. This interaction allows for Par-6 to bind to aPKC’s 
COOH-terminal PDZ ligand, which requires Cdc42. This set of interactions governs 
aPKC localization, and if any of them are disrupted, polarity within a dividing NB is 
compromised (Figure 3.5H).  
This mechanism of aPKC polarization is likely to be similar in other model 
systems, as Cdc42, Par-6, and aPKC are required for polarity in diverse tissues. While 
similar, it will be interesting to investigate the differences. For example, in NBs, this 
complex acts downstream of Baz, while in some epithelial cells Cdc42 is upstream of 
Baz (Atwood et al., 2007; Tepass, 2012). Also, epithelial cells have multiple Par-6 PDZ 
ligand proteins, such as Crumbs and Stardust, which may be playing competing roles to 
regulate aPKC localization and kinase activity (Tepass, 2012). Furthermore, we did not 
exclude the possibility of aPKC’s PDZ ligand interacting other PDZ domains, which are 
plentiful. Further investigation of other model systems will need to be done in order to 
elucidate the difference between cell types and organisms. These differences could help 
to explain why in some cancers aPKC is upregulated to drive tumorigenesis, whereas in 
others, aPKC loss leads to the upregulation of cell proliferation and tumor progression 
(Atwood et al., 2013; Guyer and Macara, 2015; Llado et al., 2015). It will be very 
important to identify these underlying differences in order to understand how to target 
aPKC activity as a therapy in these various disease states.  
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CHAPTER IV 
SUMMARY AND CONCLUDING REMARKS 
SUMMARY 
The establishment and maintenance of cell polarity is required for a myriad of 
processes during development, as well as during adulthood of organisms (Homem and 
Knoblich, 2012; Suzuki and Ohno, 2006; Tepass, 2012). In epithelial cells these include 
barrier functions and nutrient absorption. Stem cells can use polarity to asymmetrically 
divide, generating a self-renewing cell, as well as a daughter cell that go on to assume a 
particular fate based upon the intrinsic and extrinsic signals it receives (Doe, 2008). Loss 
of cell polarity, in both types of cells, is implicated in the development and progression of 
a wide variety of cancers. Drosophila neural stem cells, neuroblasts, divide 
asymmetrically to self-renew and generate a ganglion mother cell that differentiates into 
neurons or glial to populate the developing central nervous system.  They accomplish this 
by taking advantage of the evolutionarily conserved Par complex composed of Bazooka, 
Par-6, and aPKC, in close concert with the small Rho GTPase, Cdc42 (Sousa-Nunes and 
Somers, 2013). This complex is able to generate polarity in neuroblasts through the 
kinase activity of aPKC. aPKC segregates fate determinant  and proliferation regulator 
proteins to opposite side of the cell as itself, through a phosphorylation induced cortical 
displacement mechanism (Prehoda, 2009). While much is known about how aPKC is able 
to polarize its substrates, the mechanisms that govern aPKC activity and restricted 
localization are yet to be fully elucidated.  
PKC family members are regulated by post-translational modification. Of 
particular interest to this thesis is the phosphorylation of the activation loop by PDK1 and 
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subsequent autophosphorylation of the turn motif (Newton, 2010). The requirement for 
these phosphorylations in regulating aPKC was unclear, with some data suggesting they 
may not be required (Ranganathan et al., 2007; Wang et al., 2012).  In Chapter II, I report 
that PDK1 is necessary for proper development of the Drosophila central nervous 
system. Knockdown, specifically in neuroblasts, led to a reduction of neuroblasts. Upon 
closer inspection of individual dividing neuroblasts, loss of aPKC activation loop 
phosphorylation was observed, suggesting the reduction in neuroblasts could, at least in 
part, be due to misregulation of aPKC activity.  With the use of a highly quantitative in 
vitro kinase activity assay, we observed severely reduced kinase activity with the greatest 
difference being lower kcats, when we mutated either the activation loop or the turn motif. 
In order to investigate if the in vitro observed reduced activity was physiologically 
relevant; we generated transgenic Drosophila that could express proteins with a non-
phosphorylatable activation loop or a non-phosphorylatable turn motif in neuroblasts. We 
were able to determine that the activation loop and turn motif phosphorylations are 
critical for the regulation of localization and function of aPKC. Surprisingly, all the 
mutant proteins localized around the entire cortex in neuroblasts and did so independently 
of Baz and Par-6. This suggested that further studying the mechanisms involved in 
polarization of aPKC was needed.  
In embryonic neuroblasts, Baz is the first protein to polarize (Kuchinke et al., 
1998). Cdc42 acts downstream of Baz, and is required to recruit Par-6 and aPKC to the 
apical cortex (Atwood et al., 2007). In order to polarize, Par-6 and aPKC interact through 
their PB1 domains while Par-6 interacts with Cdc42 through Par-6 CRIB-PDZ (Garrard 
et al., 2003; Hutterer et al., 2004; Noda et al., 2003). Precise control of aPKC localization 
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and activity is required in neuroblasts to ensure proper development of the central 
nervous system within Drosophila larvae. Loss of aPKC in this model system leads to 
self-renewal defects, whereas inappropriate aPKC activity can lead to dramatic 
overproliferation and organismal death (Lee et al., 2006b; Rolls et al., 2003).  In Chapter 
III, I uncovered various aPKC mutant proteins that were able to localize ectopically 
around the cortex independent of Par-6, again suggesting the existence of alternative 
modes of aPKC cortical binding. This cortical binding was previously unappreciated as 
no known information about domains outside of the PB1 domain of aPKC playing a role 
in polarization have been mechanistically investigated.  
The previous model of aPKC polarization predicted that the aPKC PB1 domain 
would be sufficient for polarization through interaction with the Par-6 PB1 and Par-6’s 
interaction with Cdc42. This was not the case, as expression of aPKC’s PB1 domain 
alone was unable to polarize. The old model also predicted that removal of the PB1 
domain from aPKC would lead to its cytoplasmic localization.  To the contrary, removal 
of the PB1 domain led to completely cortical localization of the overexpressed mutant 
aPKC. While the mutant was completely cortical, it was not able to displace Mira from 
the basal cortex, indicating that it was inactive in the basal domain, likely because that PS 
was still bound to the kinase domain. This reiterated the point that aPKC contains a 
domain outside of its PB1 domain that is able to directly or indirectly get aPKC to the 
cortex. We identified this domain as the C1 domain, as it was sufficient to bind to 
phospholipids at the cortex, albeit in an unpolarized manner. It was determined that both 
the NH2- and COOH-termini of aPKC are necessary to suppress ectopic localization of 
the C1 domain, suggesting the possibility of intramolecular interactions in aPKC. Indeed, 
  
 
68 
we identified that aPKC NH2-terminal PB1/PS domains were able to interact with the 
COOH-terminus of the protein. Par-6 binding disrupts this interaction to at least partially 
activates aPKC (Graybill et al., 2012) and generate neuroblast polarity.   
 Alignment of the COOH-terminus of aPKC with human aPKC homologs 
demonstrated that aPKC contains a COOH-terminal PDZ ligand. This PDZ ligand 
interacts with the Par-6 PDZ domain, but only when GTP bound Cdc42 is present. This 
suggested a new model where aPKC interacts with Par-6 through PB1-PB1 
heterodimerization and through PDZ ligand-PDZ interaction that is regulated by Cdc42. 
These interactions must be coordinated to restrict the general cortical targeting C1 
domain to the apical cortex. This provides an elegant, albeit, slightly complex model for 
coupling aPKC localization and activation. Disruption of any of the newly identified 
protein-protein or protein-lipid interactions leads to improper polarity generation and 
subsequently improper segregation of cell fate determinants.   
 
CONCLUDING REMARKS 
My dissertation focused on the polarization of aPKC in neuroblasts, but it is likely 
that this core mechanism described here will apply to a wide range of organisms and 
tissues. This is likely since Cdc42 recruits Par-6 and aPKC in a variety of organismal 
models (Aceto et al., 2006; Atwood and Prehoda, 2009; Joberty et al., 2000; Lin et al., 
2000). However, tissue specific modulators of this core mechanism are also likely to be 
present. For example, epithelial cells utilize many PDZ domain containing proteins to 
establish polarity (Tepass, 2012). Cross talk between these PDZ containing proteins with 
aPKC PDZ ligand, or competition for Par-6 PDZ domain, or both are likely. These 
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combinatorial interactions will possibly act to regulate aPKC localization and kinase 
activity, therefore be crucial to the generation of polarity. In fact, it has already been 
demonstrated that the Par-6 PDZ domain interacts with the apical epithelial proteins 
Stardust and Crumbs, and these interactions are necessary for the establishment and 
maintenance of polarity (Hurd et al., 2003; Kempkens et al., 2006; Lemmers et al., 2004). 
These interactions can lead to differential localization of aPKC-Par-6 and Baz in some 
tissues. For example, aPKC phosphorylation of Baz, in Drosophila follicular epithelial 
cells, in combination with Crumbs competing with Baz for Par-6 binding, leads to apical 
localization of aPKC-Par-6, and sub apical Baz (Morais-de-Sá et al., 2010). How these 
interactions might influence aPKC and Par-6 PDZ ligand-PDZ interaction is yet to be 
determined, but they are likely to play a role in both activation and localization. This is in 
contrast to Drosophila neuroblasts, where Baz, aPKC, and Par-6 all colocalize, 
highlighting the necessity to further investigate the mechanisms governing aPKC activity 
and localization in a variety of cell types.  
Nonetheless, the newly identified mechanistic details identified through my 
dissertation work provide a core framework with which to move forward.  
Intriguingly, aPKC has recently been identified to signal through important cell 
fate decision pathways such as Wnt, JAK/Stat, and Hedgehog (Atwood et al., 2013; 
Guyer and Macara, 2015; Llado et al., 2015). These signaling events are often referred to 
as polarity-independent, suggesting alternative modes of aPKC regulation. Our 
understanding of the molecular mechanisms that control aPKC in these newly identified 
processes is still in its infancy, but it is clear that the atypical members of the PKC kinase 
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family are going to be important therapeutic targets (Antal et al., 2015; Atwood et al., 
2013; Justilien et al., 2014).  
aPKC can act as both an proto-oncogene, and a tumor suppressor gene, suggesting 
it will vitally important to fully understand the mechanisms that govern its regulation 
before attempting to use aPKC activity modulators as therapeutics (Antal et al., 2015; 
Parker et al., 2014). For example, treatment of BCCs and LSCCs, in which over 
activation of aPKC can to lead to tumorigenic feed back loop through Hedgehog 
signaling, should be treated differently than when loss of aPKC activity leads to 
overproliferation of intestinal stem cells through increased Wnt signaling (Atwood et al., 
2013; Justilien et al., 2014; Llado et al., 2015). Also, simply determining the level of 
aPKC expression in a tissue does not always correlate with the amount of aPKC activity. 
To the contrary, it was recently revealed that even though many disease states have 
abnormally high amounts of PKC expression, there is actually less activity, because the 
highly expressed protein is usually a mutant lacking activity (Antal et al., 2015).  
As a first step to dissecting the mechanism of aPKC regulation in these pathways, 
it should be determined if canonical aPKC regulators like Cdc42, Par6, and Par-3 are also 
playing a role, in order understand if these are truly polarity-independent signaling 
events. Determining how aPKC is regulated in these new signaling pathways will allow 
for a more mechanistic approach to choosing therapeutics that either upregulate or 
downregulate aPKC activity, depending on the cellular context, and could lead to higher 
efficacy of these treatments.  
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